Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Prostatic Neoplasms: HELP
Phillip W. Kantoff
Based on 208 articles published since 2007
||||
Expertise Level
The expertise of Phillip W. Kantoff ranks in the
  • Top 0.014%
  • ... of 129,228 published authors worldwide on Prostatic Neoplasms
  • ... from 2007 through 2018
  • ... based on contributions to 208 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
World Expert badge
similar to this:
 
Aliases Kantoff, P W   ·   Kantoff, P   ·   Kantoff, Philip   ·   Kantoff, Philip W   ·   Kantoff, Phillip W
Work Locations
Details
Most likely:    Harvard University   Contact    
2017
  • Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts. · Clinical Epidemiology Unit, Department of Medicine Solna, Karolinska Institute, Stockholm, Sweden. · Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center, Tampa, Florida. · Clinical Epidemiology and Biostatistics, Faculty of Medicine and Health, Örebro University, Örebro, Sweden. · Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden. · Faculty of Life Sciences and Medicine, King's College London, London, United Kingdom. · Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, Massachusetts. · Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Department of Epidemiology, Boston University School of Public Health, Boston, Massachusetts. · Pubmed 28152172
  • Dana-Farber Cancer Institute, Boston, Massachusetts. · University of Washington, Seattle, Washington. · Beth Israel Deaconess Medical Center, Boston, Massachusetts. · Veterans Affairs Puget Sound Health Care System, Seattle, Washington. · Beilinson Hospital, Petah Tikva, Israel. · McMaster University, Ontario, Canada. · Memorial Sloan Kettering Cancer Center, New York, New York. · Dana-Farber Cancer Institute, Boston, Massachusetts. · Pubmed 27683182
  • Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland. · Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts. · Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 28762529
  • Department of Medicine, University of Washington, Seattle, Washington. · Department of Pathology, University of Washington, Seattle, Washington. · Princess Margaret Cancer Centre, Toronto, Canada. · Department of Urologic Sciences, University of British Columbia, Vancouver, Canada. · Beth Israel Deaconess Medical Center, Boston, Massachusetts. · Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, Washington. · Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington. · BC Cancer Agency and University of British Columbia, Vancouver, Canada. · Department of Urology, University of Washington, Seattle, Washington. · Department of Urology, Emory University, Atlanta, Georgia. · Medivation, Inc., San Francisco, California. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Memorial Sloan Kettering Cancer Center, New York, New York. · Geriatric Research, Education and Clinical Center, VA Puget Sound Health Care System, and Department of Medicine, Division of Gerontology & Geriatric Medicine, University of Washington, Seattle, Washington. · Department of Medicine, University of Washington, Seattle, Washington. · Brigham and Women's Hospital, Boston, Massachusetts. · Astellas Pharma, Inc., Northbrook, Illinois. · Pubmed 28151719
  • Dana-Farber Cancer Institute, Boston, Massachusetts. · Harvard Medical School, Boston, Massachusetts. · Broad Institute of Harvard and MIT, Cambridge, Massachusetts. · Brigham and Women's Hospital, Boston, Massachusetts. · Dana-Farber Cancer Institute, Boston, Massachusetts. · Pubmed 27899381
  • Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Urology and Medicine, Tulane University School of Medicine, New Orleans, Los Angeles. · Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 27489290
2016
  • Department of Medical Oncology, BC Cancer Agency, Vancouver, Canada · Janssen Research & Development, San Diego. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco. · Janssen Research & Development, Menlo Park. · Department of Solid Tumor Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston. · Comprehensive Cancer Centers of Nevada, Las Vegas. · Department of Oncology and Internal Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, USA. · Groupe Uro-Genitologie, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Johnson & Johnson Medical China, Shanghai, China. · Department of Medical Oncology, BC Cancer Agency, Vancouver, Canada. · Tom Baker Cancer Center and University of Calgary, Calgary. · Department of Medical Oncology, Princess Margaret Hospital and University of Toronto, Toronto, Canada. · Drug Development Unit, Division of Cancer Therapeutics/Clinical Studies, The Institute for Cancer Research and Royal Marsden Hospital, Sutton, UK. · Genitourinary Oncology Service, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, USA. · Pubmed 26685010
  • The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins Medical Institutions, Baltimore, Maryland. · The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins Medical Institutions, Baltimore, Maryland Department of Medical Oncology, Johns Hopkins Medical Institutions, Baltimore, Maryland The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins Medical Institutions, Baltimore, Maryland; and. · Department of Medical Oncology, Johns Hopkins Medical Institutions, Baltimore, Maryland. · The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins Medical Institutions, Baltimore, Maryland; and. · Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins Medical Institutions, Baltimore, Maryland · Pubmed 26493203
  • Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Pubmed 27502737
  • Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. · Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. · Interne de Paris, Urology, Paris, France. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Cancer Biology, Cleveland Clinic, Cleveland, Ohio. · Pubmed 27325180
  • Departments Of Epidemiology & Biostatistics and Urology, University of CA San Francisco. · SWOG Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, WA. · Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston MA. · Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital/Harvard Medical School, Boston, MA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston MA. · Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan Cancer Center, Michigan. · Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH. · The Cancer Therapy and Research Center, University of Texas Health Science Center at San Antonio, San Antonio, TX. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 27197287
  • Department of Urology, Osaka Medical College, Osaka 569-8686, Japan; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065; · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215; · Department of Urology, Osaka Medical College, Osaka 569-8686, Japan; · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065; · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215; Harvard Medical School, Boston, MA 02215 · Pubmed 27185910
  • Shanghai Key Laboratory of Tuberculosis, Shanghai Pulmonary Hospital, Shanghai 200433, China. · Department of Bioinformatics, School of Life Sciences and Technology, Tongji University, Shanghai 200092, China. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA. · Harvard Medical School, Boston, Massachusetts 02215, USA. · Department of Pathology, University of Massachusetts Medical School, Worcester, Massachusetts 01655, USA. · Department of Molecular and Cellular Biology, Harvard University, Cambridge, Massachusetts 02138, USA. · Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, Massachusetts 02138, USA. · Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, Massachusetts 02142, USA. · Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA. · Department of Pathology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA. · Department of Bioinformatics and Computational Biology, Division of Quantitative Sciences, University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. · Department of Medicine Memorial Sloan Kettering Cancer Center 1275 York Avenue, New York, New York 10065, USA. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute and Harvard School of Public Health, Boston, Massachusetts 02215, USA. · Pubmed 26975529
  • Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. · Department of Epidemiology and Biostatistics and Urology, University of California, San Francisco, California. · Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts. · Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts. · Pubmed 26847995
  • Harvard-MIT Division of Health Sciences and Technology, Harvard Medical School, Boston, MA. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. · Gelb Center for Translational Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. · Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. · Department of Radiation Oncology, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. Electronic address: · Pubmed 26778006
  • Department of Radiology, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA. Electronic address: · Department of Radiology, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA. · Harvard Medical School, Boston, MA, USA; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. · Pubmed 26767544
  • Department of Pathology, University of Michigan Health System, Ann Arbor, MI, USA; Comprehensive Cancer Center, University of Michigan Health System, Ann Arbor, MI, USA; Michigan Center for Translational Pathology, Ann Arbor, MI, USA. Electronic address: · Department of Pathology, University of Michigan Health System, Ann Arbor, MI, USA. · Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, MA, USA. · Michigan Center for Translational Pathology, Ann Arbor, MI, USA. · Comprehensive Cancer Center, University of Michigan Health System, Ann Arbor, MI, USA; Michigan Center for Translational Pathology, Ann Arbor, MI, USA; Department of Radiation Oncology, University of Michigan Health System, Ann Arbor, MI, USA. · Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. · Department of Pathology, University of Michigan Health System, Ann Arbor, MI, USA; Comprehensive Cancer Center, University of Michigan Health System, Ann Arbor, MI, USA; Michigan Center for Translational Pathology, Ann Arbor, MI, USA; Howard Hughes Medical Institute, Ann Arbor, MI, USA. Electronic address: · Pubmed 26724257
  • All authors: Dana-Farber Cancer Institute, Boston, MA. · All authors: Dana-Farber Cancer Institute, Boston, MA. · Pubmed 26668348
  • Center for Surgery and Public Health, Division of Urologic Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts2Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Center for Surgery and Public Health, Division of Urologic Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. · Dana-Farber Cancer Institute, Department of Medical Oncology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. · Vattikuti Urology Institute, Henry Ford Health System, Detroit, Michigan. · Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Center for Community-Based Research, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. · Dana-Farber Cancer Institute, Department of Radiation Oncology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. · Pubmed 26502115
  • Department of Radiation Oncology, Dana Farber Cancer Institute, Boston, Massachusetts. · Department of Statistics, University of Connecticut, Storrs. · Department of Medicine, Dana Farber Cancer Institute, Boston, Massachusetts. · Pubmed 26954420
2015
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. Electronic address: · Pubmed 25577717
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA. · Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA. · Channing Laboratory, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · Pubmed 25531313
  • Centers for Cancer Pharmacology and Excellence of Environmental Toxicology (CEET), Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104-6160, USA. · Fred Hutchinson Cancer Center, University of Washington, Seattle, WA 98109, USA. · Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA. · Dana Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA. · Centers for Cancer Pharmacology and Excellence of Environmental Toxicology (CEET), Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104-6160, USA. Electronic address: · Pubmed 25514466
  • Department of Radiation Oncology, Dana-Farber/Brigham and Women's Cancer Center, Boston, MA, USA. Electronic address: · Department of Medicine, University Health Network, Toronto, Canada. · Section on Men's Health, Aging and Metabolism, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · Department of Radiation Oncology, Dana-Farber/Brigham and Women's Cancer Center, Boston, MA, USA. · Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · Division of General Internal Medicine, Department of Medicine, Brigham and Women's Hospital, and Department of Health Care Policy, Harvard Medical School, Boston, MA, USA. · Department of Urologic Surgery and the Center for Surgical Quality and Outcomes Research, Vanderbilt University, and the VA Tennessee Valley Geriatric Research, Education, and Clinical Center, Nashville, TN, USA. · Academic Urology Unit, Department of Oncology, Royal Hallamshire Hospital, University of Sheffield, Sheffield, UK. · Division of Urology, Cliniques Universitaires Saint Luc, Université Catholique de Louvain, Brussels, Belgium. · Department of Hematology-Oncology, Massachusetts General Hospital Cancer Center, Boston, MA, USA. · Pubmed 25097095
  • Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Genitourinary Medical Oncology, Beth Israel Deaconess Medical Center, Boston, Massachusetts. · Genitourinary Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York. · Medical Oncology/Hematology Program, Greenebaum Cancer Center, Baltimore, Maryland. · Pubmed 25903013
  • Dendreon Corporation, Seattle, Washington. · Mount Sinai School of Medicine, New York, New York. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · University of Washington School of Medicine and Fred Hutchinson Cancer Research Center, Seattle, Washington. · University of California, San Francisco, San Francisco, California. · Indiana University Simon Cancer Center, Indianapolis, Indiana. · Dendreon Corporation, Seattle, Washington. · Johns Hopkins University School of Medicine, the Brady Urological Institute, Baltimore, Maryland. · Pubmed 25649018
  • Medical Oncology, Dana-Farber Cancer Institute and Internal Medicine, Harvard Medical School, Boston, MA. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA. · Department of Imaging, Dana-Farber Cancer Institute, Department of Radiology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA. · Knight Cancer Institute at Oregon Health and Science University, Portland, OR. · Medical Oncology, Dana-Farber Cancer Institute and Internal Medicine, Harvard Medical School, Boston, MA; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA. · Medical Oncology, Dana-Farber Cancer Institute and Internal Medicine, Harvard Medical School, Boston, MA. Electronic address: · Pubmed 25450031
  • Center for Surgery and Public Health, Brigham and Women's Hospital, Boston, Massachusetts. · VUI Center for Outcomes Research, Analytics and Evaluation, Henry Ford Health System, Detroit, Michigan. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Pubmed 26575066
  • Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts. · Department of Epidemiology, University of Florida, Gainesville, Florida. · Department of Radiation Oncology, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Boston, Massachusetts. · Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts. · Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, Massachusetts. · Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Pubmed 26469352
  • Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA. · Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. · The Eli and Edythe L. Broad Institute, Cambridge, Massachusetts, USA. · Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA. · Pubmed 26457646
  • Department of Radiation Oncology, Brigham and Women's Hospital, Boston, Massachusetts. · Department of Statistics, University of Connecticut, Storrs. · Department of Pathology, Miami Baptist Hospital, Miami, Florida. · Department of Medicine, Dana Farber Cancer Institute, Boston, Massachusetts. · Pubmed 26393854
  • Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Pubmed 26289068
  • Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Gelb Center for Translational Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Gelb Center for Translational Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts4Department of Urology, Shanghai Jiao Tong University School of Medicine, Xinhua Hospital, Shanghai, China. · Apple Tree Partners, New York, New York. · Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts. · Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts2Gelb Center for Translational Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Pubmed 26181260
  • Department of Radiation Oncology, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts. · Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts. Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. · Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts. Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · School of Health and Medical Sciences, Örebro University; and Department of Urology, Örebro University Hospital, Örebro, Sweden. · Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts. Pathology Unit, Addarii Institute, S Orsola-Malpighi Hospital, Bologna, Italy. · Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts. Department of Pathology, Trinity College, Dublin, Ireland. · Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts. Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. Broad Institute of Harvard and MIT, Cambridge, Massachusetts. Division of Cancer Studies, King's College London, London, United Kingdom. · Pubmed 26124442
  • Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA 02142, USA. · Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA. · Department of Pathology and Laboratory Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; Institute for Precision Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; New York Presbyterian Hospital, New York, NY 10021, USA; Meyer Cancer, Weill Medical College of Cornell University, New York, NY 10021, USA. · Computational Biology Program, Public Health Sciences Division and Basic Science Division, Fred Hutchinson Cancer Center, University of Washington, Seattle, WA 98109, USA; Department of Medicine and VAPSHCS, University of Washington, Seattle, WA 98109, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA. · Department of Laboratory Medicine, University of Washington, Seattle, WA 98195, USA. · Cancer Biomarkers Team, Division of Clinical Studies, The Institute of Cancer Research, London SM2 5NG, UK; Prostate Cancer Targeted Therapy Group and Drug Development Unit, The Royal Marsden NHS Foundation Trust, London SM2 5NG, UK. · Institute for Precision Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; New York Presbyterian Hospital, New York, NY 10021, USA; Department of Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; Meyer Cancer, Weill Medical College of Cornell University, New York, NY 10021, USA. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Genitourinary Oncology Service, Department of Medicine, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Computational Biology Program, Public Health Sciences Division and Basic Science Division, Fred Hutchinson Cancer Center, University of Washington, Seattle, WA 98109, USA. · Prostate Cancer Clinical Trials Consortium, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Howard Hughes Medical Institute, University of Michigan, Ann Arbor, MI 48109, USA. · Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, MI 48109, USA. · Department of Internal Medicine, Division of Hematology Oncology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Urology, University of Michigan Medical School, Ann Arbor, MI 48109, USA. · Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Radiation Oncology, University of Michigan Medical School, Ann Arbor, MI 48109, USA. · Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Urology, University of Michigan Medical School, Ann Arbor, MI 48109, USA. · Department of Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Genitourinary Oncology Service, Department of Medicine, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; Genitourinary Oncology Service, Department of Medicine, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Interventional Radiology, Department of Radiology Service, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA 02142, USA; Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Pathology, Brigham & Women's Hospital, Boston, MA 02115, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA 02215, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Pathology, Brigham & Women's Hospital, Boston, MA 02115, USA. · Division of Hematology-Oncology, Department of Medicine, Beth Israel Deaconess Cancer Center, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA. · Department of Musculoskeletal Radiology, Brigham and Women's Hospital, Boston, MA 02115, USA. · Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA 02142, USA. · Department of Medicine and VAPSHCS, University of Washington, Seattle, WA 98109, USA. · Department of Radiology, University of Washington, Seattle, WA 98109, USA. · Department of Pathology, University of Washington Medical Center, Seattle, WA 98109, USA. · Institute for Precision Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; Laboratory of Computational Oncology, CIBIO, Centre for Integrative Biology, University of Trento, 38123 Mattarello TN, Italy. · Institute for Precision Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; Division of Interventional Radiology, Department of Radiology, New York-Presbyterian Hospital/Weill Cornell Medical Center, New York, NY 10021, USA; Meyer Cancer, Weill Medical College of Cornell University, New York, NY 10021, USA. · Institute for Precision Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; Institute for Computational Biomedicine, Department of Physiology and Biophysics, Weill Medical College of Cornell University, New York, NY 10021, USA; Department of Physiology & Biophysics, Weill Medical College of Cornell University, New York, NY 10021, USA. · Institute for Computational Biomedicine, Department of Physiology and Biophysics, Weill Medical College of Cornell University, New York, NY 10021, USA. · Department of Pathology and Laboratory Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; Institute for Precision Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; Institute for Computational Biomedicine, Department of Physiology and Biophysics, Weill Medical College of Cornell University, New York, NY 10021, USA; Meyer Cancer, Weill Medical College of Cornell University, New York, NY 10021, USA. · Department of Oncology, Wayne State University School of Medicine, Detroit, MI 48201, USA; Molecular Therapeutics Program, Barbara Ann Karmanos Cancer Institute, Detroit, MI 48201, USA. · The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins School of Medicine, Baltimore, MD 21205, USA. · Department of Medicine and VAPSHCS, University of Washington, Seattle, WA 98109, USA; Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA; Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA; Meyer Cancer, Weill Medical College of Cornell University, New York, NY 10021, USA. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Howard Hughes Medical Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. Electronic address: · Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Urology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Howard Hughes Medical Institute, University of Michigan, Ann Arbor, MI 48109, USA. Electronic address: · Pubmed 26000489
  • Radiation Oncology, Brigham and Women's Hospital and Dana-Farber Cancer Institute, Boston, MA (P.L.N., P.L.G., A.H.). · Department of Pathology, Brigham and Women's Hospital, Boston, MA (P.J.). · Endocrinology, Brigham and Women's Hospital, Boston, MA (S.B.). · Cardiovascular Division, Brigham and Women's Hospital, Boston, MA (J.P.Z., J.M., S.K., J.A.B.). · Medical Oncology, Dana-Farber Cancer Institute, Boston, MA (P.W.K.). · Pubmed 25896892
  • Department of Medical Oncology, and. · Department of Medical Oncology, and Broad Institute, Cambridge, Massachusetts. · Hematology-Oncology Division, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts. · Department of Medical Oncology, and Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. · Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada. Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada. · Division of Clinical Research, Fred Hutchinson Cancer Research Center and Department of Medicine, University of Washington School of Medicine, Seattle, Washington. · Department of Medical Oncology, and Broad Institute, Cambridge, Massachusetts. · Department of Medical Oncology, and · Pubmed 25808865
  • Metamark Genetics Inc., Cambridge, Massachusetts. · Department of Pathology and Molecular Medicine, Queen's University, Kingston, Ontario, Canada. · Department of Pathology, Yale University Medical School, New Haven, Connecticut. · Urology Austin, Austin, Texas. · Impacts Inc., Montreal, Quebec, Canada. · Dana-Farber Cancer Institute, Boston, Massachusetts. · Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, Ohio. · Department of Anatomic Pathology, Cleveland Clinic, Cleveland, Ohio. · Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada. · Department of Pathology, Urology and Oncology, Johns Hopkins Hospital, Baltimore, Maryland. · Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada. · Pubmed 25733599
  • Department of Radiation Oncology, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Boston, MA. Electronic address: · Department of Epidemiology, Harvard School of Public Health, Boston, MA. · Departments of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA. · Department of Epidemiology, Harvard School of Public Health, Boston, MA; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA. · Department of Radiation Oncology, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Boston, MA. · Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA. · Pubmed 25662905
  • Division of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York. Electronic address: · Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Department of Pathology, David Geffen School of Medicine at University of California-Los Angeles, Los Angeles, California. · Division of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York. · Pubmed 25623747
  • Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · University of Washington, Seattle, Washington. · University of Texas MD Anderson Cancer Center, Houston, Texas. · University of Washington, Seattle, Washington. Fred Hutchinson Cancer Research Center, Seattle, Washington. · Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Pubmed 25320358
  • Department of Radiation Oncology, Dana Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA. · Department of Statistics, University of Connecticut, Storrs, CT. · Department of Radiation Oncology, Boston Medical Center, Boston University School of Medicine, Boston, MA. · Department of Medical Oncology, Dana Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA. · Department of Radiation Oncology, Dana Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA. Electronic address: · Pubmed 25103271
2014
  • Department of Medicine, University of Wisconsin Carbone Cancer Center, Madison, Wisconsin. · Department of Urology, Indiana University Simon Cancer Center, Indianapolis, Indiana. · Department of Medicine, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, Washington. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco Comprehensive Cancer Center, San Francisco, California. · Department of Laboratory Medicine, University of Washington, Seattle, Washington. · Dendreon Corporation, Seattle, Washington. · Department of Solid Tumor Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio. · Pubmed 25189164
  • Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. · 1] Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada [2] Brigham and Women's Hospital, Boston, MA, USA. · Beth Israel Deaconess Medical Center, Boston, MA, USA. · 1] Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA, USA [2] Brigham and Women's Hospital, Boston, MA, USA. · Brigham and Women's Hospital, Boston, MA, USA. · Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA, USA. · Pubmed 25091040
  • Vattikuti Urology Institute Center for Outcomes Research, Analytics, and Evaluation, Henry Ford Health System, Detroit, Michigan. · Division of Urologic Surgery, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Vattikuti Urology Institute Center for Outcomes Research, Analytics, and Evaluation, Henry Ford Health System, Detroit, Michigan2Division of Urologic Surgery, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Boston, Massachusetts4Center for Sur. · Pubmed 25179266
  • Helen Diller Family Comprehensive Cancer Center, University of California at San Francisco, San Francisco, CA, USA. · Departments of Oncology and Urology, School of Medicine, University of Washington, Seattle, WA, USA. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Dendreon Corporation, Seattle, WA, USA. · Smilow Cancer Center, Yale University, New Haven, CT, USA. · Pubmed 24957547
  • Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts. · Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts. · Department of Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts. Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts. Department of Nutrition, Harvard School of Public Health, Boston, Massachusetts. Channing Division of Network Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. · Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts. Department of Biostatistics, Harvard School of Public Health, Boston, Massachusetts. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts. Channing Division of Network Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. · Pubmed 24925673
  • Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02115; · Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02115;Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215; · Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215;Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute and Harvard School of Public Health, Boston, MA 02115; and. · Hematology-Oncology Division, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02215. · Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02115; · Pubmed 24778216
  • 1] The Eli and Edythe L. Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA. [2] Dana-Farber Cancer Institute, Boston, Massachusetts, USA. [3] Harvard Medical School, Boston, Massachusetts, USA. [4]. · 1] The Eli and Edythe L. Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA. [2] Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA. [3]. · 1] The Eli and Edythe L. Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA. [2]. · 1] The Eli and Edythe L. Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA. [2] Dana-Farber Cancer Institute, Boston, Massachusetts, USA. [3] Harvard Medical School, Boston, Massachusetts, USA. · The Eli and Edythe L. Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA. · 1] The Eli and Edythe L. Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA. [2] Dana-Farber Cancer Institute, Boston, Massachusetts, USA. · Department of Chemistry and Chemical Biology, Harvard University, Cambridge, Massachusetts, USA. · Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA. · Brigham and Women's Hospital, Boston, Massachusetts, USA. · 1] Dana-Farber Cancer Institute, Boston, Massachusetts, USA. [2] Harvard Medical School, Boston, Massachusetts, USA. · Dana-Farber Cancer Institute, Boston, Massachusetts, USA. · Massachusetts General Hospital, Boston, Massachusetts, USA. · 1] Dana-Farber Cancer Institute, Boston, Massachusetts, USA. [2] Harvard Medical School, Boston, Massachusetts, USA. [3] Brigham and Women's Hospital, Boston, Massachusetts, USA. · 1] The Eli and Edythe L. Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA. [2] Dana-Farber Cancer Institute, Boston, Massachusetts, USA. [3] Harvard Medical School, Boston, Massachusetts, USA. [4] Brigham and Women's Hospital, Boston, Massachusetts, USA. · 1] The Eli and Edythe L. Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA. [2] Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA. [3] Howard Hughes Medical Institute, Chevy Chase, Maryland, USA. · 1] The Eli and Edythe L. Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA. [2] Dana-Farber Cancer Institute, Boston, Massachusetts, USA. [3] Harvard Medical School, Boston, Massachusetts, USA. [4] Howard Hughes Medical Institute, Chevy Chase, Maryland, USA. · 1] The Eli and Edythe L. Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA. [2] Massachusetts General Hospital, Boston, Massachusetts, USA. · 1] The Eli and Edythe L. Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA. [2] Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA. [3] Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, USA. · Pubmed 24752078
  • Perini Family Survivors' Center, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA. Electronic address: · Perini Family Survivors' Center, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA. · Division of Urology, Brigham and Women's Hospital, 45 Francis Street, Boston, Boston, MA 02115, USA. · Division of Solid Tumor Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA. · Pubmed 24495697
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · 1] Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA [2] Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Cancer Biology Program, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA. · Pubmed 23770851
2013
  • The Lank Center for Genitourinary Oncology and Solid Tumor Oncology at Dana-Farber Cancer Institute/Brigham & Women's Hospital, Boston, Massachusetts 02115, USA. · Pubmed 23704236
2012
  • Lank Center for Genitourinary Oncology, Division of Solid Tumor Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA. · Pubmed 23040162
  • Departmentof Medical Oncology, Dana Farber Cancer, Institute, Harvard Medical School, 450 Brookline Ave., Boston, Massachusetts 02115. · Departmentof Medicine, Beth Israel Deaconess Medical, Center, Harvard Medical School, 330 Brookline Ave., Boston, Massachusetts 02115. · Pubmed 22127852
2010
  • Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA. · Pubmed 20818862
2017
  • Wanling Xie, Meredith M. Regan, and Christopher J. Sweeney, Dana-Farber Cancer Institute, Boston, MA; Marc Buyse, International Drug Development Institute; Bertrand Tombal, Université Catholique de Louvain, Louvain-la-Neuve; Laurence Collette, European Organisation for Research and Treatment of Cancer, Brussels, Belgium; Susan Halabi, Duke University Medical Center, Durham, NC; Philip W. Kantoff, Memorial Sloan Kettering Cancer Center, New York, NY; Oliver Sartor, Tulane Medical School, New Orleans, LA; Howard Soule, Prostate Cancer Foundation, Santa Monica; Howard M. Sandler, Cedars-Sinai Medical Center, Los Angeles, CA; Noel W. Clarke, The Christie NHS Foundation Trust, Manchester; Matthew R. Sydes, University College London, London, United Kingdom; James J. Dignam, University of Chicago, Chicago, IL; Karim Fizazi, Institut Gustave-Roussy, Villejuif, France; Wendy R. Paruleker, Canadian Cancer Trials Group, Kingston, Ontario, Canada; and Scott G. Williams, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Pubmed 28796587
2016
  • Howard I. Scher, Michael J. Morris, Dana E. Rathkopf, and Susan F. Slovin, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College; David Nanus, NewYork Presbyterian Weill Cornell Medical Center; Lawrence W. Schwartz, NewYork Presbyterian Columbia University Medical Center, New York, NY; Walter M. Stadler, University of Chicago Medicine, Chicago, IL; Celestina Higano and Peter S. Nelson, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, WA; Ethan Basch, University of North Carolina at Chapel Hill, Chapel Hill, NC; Emmanual S. Antonarakis and Michael A. Carducci, Johns Hopkins University School of Medicine, Baltimore, MD; Tomasz M. Beer, Oregon Health and Science University, Portland, OR; Paul G. Corn and Christopher Logothetis, MD Anderson Cancer Center, Houston, TX; Robert Dreicer, University of Virginia School of Medicine, Charlottesville, VA; Daniel J. George, Susan Halabi, and Andrew J. Armstrong, Duke University and Duke Cancer Institute, Durham, NC; Elisabeth I. Heath, Wayne State University Karmanos Cancer Institute, Detroit; and Maha Hussain, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; Wm. Kevin Kelly, Sidney Kimmel School of Medicine at Thomas Jefferson University, Philadelphia, PA; Glenn Liu and George Wilding, University of Wisconsin Carbone Cancer Center, Madison, WI; Mark N. Stein, The Cancer Institute of New Jersey, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, New Brunswick, NJ; Charles S. Ryan and Eric J. Small, University of California Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Oliver Sartor, Tulane School of Medicine, New Orleans, LA; Matthew Raymond Smith, Massachusetts General Hospital Cancer Center and Harvard Medical School; Mary-Ellen Taplin and Philip W. Kantoff, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, Franc · Pubmed 26903579
  • Rana R. McKay, Lillian Werner, Christopher J. Sweeney, Philip W. Kantoff, and Mary-Ellen Taplin, Dana-Farber Cancer Institute, Boston; Robert W. Ross, Bluebird Bio, Cambridge, MA; Amado J. Zurita and Hai T. Tran, MD Anderson Cancer Center, Houston, TX; Justine Y. Bruce, University of Wisconsin Carbone Cancer Center, Madison, WI; Michael A. Carducci, Johns Hopkins University; Arif Hussain, Greenebaum Cancer Center, Baltimore, MD; Mark N. Stein, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ; Elisabeth I. Heath, Karmanos Cancer Institute, Detroit, MI; and Philip W. Kantoff and Susan F. Slovin, Memorial Sloan Kettering Cancer Center, New York, NY. · Rana R. McKay, Lillian Werner, Christopher J. Sweeney, Philip W. Kantoff, and Mary-Ellen Taplin, Dana-Farber Cancer Institute, Boston; Robert W. Ross, Bluebird Bio, Cambridge, MA; Amado J. Zurita and Hai T. Tran, MD Anderson Cancer Center, Houston, TX; Justine Y. Bruce, University of Wisconsin Carbone Cancer Center, Madison, WI; Michael A. Carducci, Johns Hopkins University; Arif Hussain, Greenebaum Cancer Center, Baltimore, MD; Mark N. Stein, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ; Elisabeth I. Heath, Karmanos Cancer Institute, Detroit, MI; and Philip W. Kantoff and Susan F. Slovin, Memorial Sloan Kettering Cancer Center, New York, NY. · Pubmed 27044933
  • Nicholas J. Giacalone, Marian Loffredo, and Anthony V. D'Amico, Brigham and Women's Hospital/Dana-Farber Cancer Institute; Nicholas J. Giacalone, Harvard Radiation Oncology Program, Boston, MA; Jing Wu and Ming-Hui Chen, University of Connecticut, Storrs, CT; Andrew Renshaw, Miami Baptist Hospital, Miami, FL; and Philip W. Kantoff, Memorial Sloan Kettering Cancer Center, New York, NY. · Pubmed 27601545
  • From the University of Washington (C.C.P., M. Beightol, C.M., B.N., H.H.C., B.M., T.W., S. Casadei, P.S.N.) and Fred Hutchinson Cancer Research Center (N.D.S., R.G., P.S.N.) - both in Seattle; the Institute of Cancer Research and Royal Marsden Hospital, London (J.M., S. Carreira, R.E., J.B.); Memorial Sloan Kettering Cancer Center (M.F.W., W.A., M. Berger, L.Z., A.Z., J. Vijai, H.I.S., C.S., N.S., P.W.K., D.S., M.R., K.O.), Weill Cornell Medical College (H.B., O.E., M.A.R.), and the Prostate Cancer Clinical Trials Consortium (J. Vinson, J.F.) - all in New York; the University of Michigan, Ann Arbor (D.R., R.L., M.H., A.C.); Howard Hughes Medical Institute, Chevy Chase, MD (A.C., C.S.); and Dana-Farber Cancer Institute, Boston (A.G., L.G., M.-E.T., S.A., G.C.H., E.M.V.A.). · Pubmed 27433846
2015
  • Michael J. Morris, Steven M. Larson, and Howard I. Scher, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY; Arturo Molina, Thian Kheoh, Shannon L. Matheny, Vahid Naini, and Thomas W. Griffin, Janssen Research & Development, Los Angeles; Eric J. Small and Charles J. Ryan, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA; Johann S. de Bono, Institute for Cancer Research and Royal Marsden Hospital, Sutton, United Kingdom; Christopher J. Logothetis, MD Anderson Cancer Center, Houston, TX; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, France; Paul de Souza, University of Western Sydney School of Medicine, Ingham Institute, Liverpool, New South Wales, Australia; Philip W. Kantoff, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; Celestia S. Higano, University of Washington, Seattle, WA; Jinhui Li, Janssen Research & Development, Raritan, NJ; and Tomasz Burzykowski, International Drug Development Institute, Louvain-la-Neuve, Belgium. · Michael J. Morris, Steven M. Larson, and Howard I. Scher, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY; Arturo Molina, Thian Kheoh, Shannon L. Matheny, Vahid Naini, and Thomas W. Griffin, Janssen Research & Development, Los Angeles; Eric J. Small and Charles J. Ryan, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA; Johann S. de Bono, Institute for Cancer Research and Royal Marsden Hospital, Sutton, United Kingdom; Christopher J. Logothetis, MD Anderson Cancer Center, Houston, TX; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, France; Paul de Souza, University of Western Sydney School of Medicine, Ingham Institute, Liverpool, New South Wales, Australia; Philip W. Kantoff, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; Celestia S. Higano, University of Washington, Seattle, WA; Jinhui Li, Janssen Research & Development, Raritan, NJ; and Tomasz Burzykowski, International Drug Development Institute, Louvain-la-Neuve, Belgium. · Pubmed 25624432
  • Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA. · Pubmed 25135206
2014
  • Mary-Ellen Taplin, Massimo Loda, Rosina T. Lis, Wanling Xie, Zhenyang Jiang, and Philip W. Kantoff, Dana-Farber Cancer Institute, Harvard Medical School; Glenn J. Bubley, Huihui Ye, and Steven P. Balk, Beth Israel Deaconess Medical Center; Jerome P. Richie, Massimo Loda, and Rosina T. Lis, Brigham and Women's Hospital, Boston, MA; Bruce Montgomery, Bruce L. Dalkin, Lawrence D. True, and Alvin M. Matsumoto, University of Washington; Brett T. Marck and Alvin M. Matsumoto, Geriatric Research, Education and Clinical Center, Veterans' Affairs Puget Sound Health Care System; Elahe A. Mostaghel and Peter S. Nelson, Fred Hutchinson Cancer Research Center, Seattle, WA; Christopher J. Logothetis, John W. Davis, and Patricia Troncoso, University of Texas MD Anderson Cancer Center, Houston, TX; Martin G. Sanda, Emory University School of Medicine, Atlanta, GA; Massimo Loda, King's College London, London, United Kingdom; Trevor M. Penning and Daniel Tamae, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; and Christopher M. Haqq, NamPhuong Tran, Weimin Peng, Thian Kheoh, and Arturo Molina, Janssen Research and Development, Los Angeles, CA. · Mary-Ellen Taplin, Massimo Loda, Rosina T. Lis, Wanling Xie, Zhenyang Jiang, and Philip W. Kantoff, Dana-Farber Cancer Institute, Harvard Medical School; Glenn J. Bubley, Huihui Ye, and Steven P. Balk, Beth Israel Deaconess Medical Center; Jerome P. Richie, Massimo Loda, and Rosina T. Lis, Brigham and Women's Hospital, Boston, MA; Bruce Montgomery, Bruce L. Dalkin, Lawrence D. True, and Alvin M. Matsumoto, University of Washington; Brett T. Marck and Alvin M. Matsumoto, Geriatric Research, Education and Clinical Center, Veterans' Affairs Puget Sound Health Care System; Elahe A. Mostaghel and Peter S. Nelson, Fred Hutchinson Cancer Research Center, Seattle, WA; Christopher J. Logothetis, John W. Davis, and Patricia Troncoso, University of Texas MD Anderson Cancer Center, Houston, TX; Martin G. Sanda, Emory University School of Medicine, Atlanta, GA; Massimo Loda, King's College London, London, United Kingdom; Trevor M. Penning and Daniel Tamae, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; and Christopher M. Haqq, NamPhuong Tran, Weimin Peng, Thian Kheoh, and Arturo Molina, Janssen Research and Development, Los Angeles, CA. · Pubmed 25311217
  • Perini Family Survivors' Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Pubmed 24962506
  • Department of Medicine, Dana-Farber Cancer Institute, Boston, Massachusetts. · Pubmed 24668612
  • Harvard Radiation Oncology Program, Harvard Medical School, Boston, Massachusetts. · Pubmed 24604289
  • Elahe A. Mostaghel, Rachel Hunter Merrill, and Roman Gulati, Fred Hutchinson Cancer Research Center; Elahe A. Mostaghel, Peter S. Nelson, Paul Lange, Daniel W. Lin, William Ellis, Robert Vessella, and Bruce Montgomery, University of Washington; Brett Marck, Alvin M. Matsumoto, and Lawrence D. True, Veterans Affairs Puget Sound Health Care System, Seattle, WA; Mary Ellen Taplin and Philip Kantoff, Dana-Farber Cancer Institute, Harvard Medical School; Steven Balk, Beth Israel Deaconess Medical Center, Boston, MA; and Daniel Tamae and Trevor Penning, University of Pennsylvania, Philadelphia, PA. · Pubmed 24323034
  • Department of Medicine, Dana-Farber Cancer Institute, Boston, Massachusetts. · Pubmed 24132762
2013
  • Affiliations of authors: Department of Epidemiology (AP, AM, MF, REG, KLP, JRR, EJN, MJS, ELG, LAM) and Department of Nutrition (MJS, ELG), Harvard School of Public Health, Boston, MA; Channing Division of Network Medicine (AP, KLP, JRR, MJS, ELG, LAM) and Division of Preventive Medicine (HDS) , Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA; Department of Pathology, Brigham and Women's Hospital, Boston, MA (RTL, ECS, ML); Center for Molecular Oncologic Pathology (RTL, RF, ECS, MF, SF, NEM, ML), Department of Radiation Oncology (NEM), and Lank Center for Genitourinary Oncology (PWK), Dana-Farber Cancer Institute, Boston, MA; University of Dublin, Trinity College, Dublin, Ireland (RF, SF); Pathology Unit, Addarii Institute, S. Orsola-Malpighi Hospital, Bologna, Italy (MF); Department of Medicine, McGill University, Montreal, QC, Canada (MP). · Pubmed 24292212
  • Harvard Radiation Oncology Program, Harvard Medical School, Boston, Massachusetts. · Pubmed 23798006
  • Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Institute for Clinical and Economic Review, Institute for Technology Assessment, Boston, MA 02115, USA. · Pubmed 23778902
  • Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute and Harvard Medical School, 450 Brookline Avenue, Boston, MA 02215, USA. · Pubmed 23719969
  • Harvard Medical School, Boston, MA 02115, USA. · Pubmed 23622249
  • Harvard Radiation Oncology Program, Boston, Massachusetts, USA. · Pubmed 23382116
  • Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts 02215, USA. · Pubmed 22887127
  • The Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. · Pubmed 24114731
2012
  • Lank Center for Genitourinary Oncology, Department of Medicine, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02215, USA. · Pubmed 22928480
  • Dana Farber Cancer Institute, Boston, Massachusetts, USA. · Pubmed 22282219
  • Massachusetts General Hospital Cancer Center, Boston, MA 02114, USA. · Pubmed 21930687
  • Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA. · Pubmed 23413607
  • Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA. · Pubmed 23239736
  • Dana-Farber Cancer Institute, 450 Brookline Ave., Boston, MA 02215, USA. · Pubmed 23138168
  • Division of Solid Tumor Oncology, Department of Medicine, Dana-Farber Cancer Institute, Boston, MA, USA. · Pubmed 23059047
  • Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA. · Pubmed 22736790
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA. · Pubmed 22730461
  • Department of Radiation Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. · Pubmed 22564379
  • Harvard Radiation Oncology Program, Department of Radiation Oncology, Dana Farber Cancer Institute, Boston, Massachusetts 02115, USA. · Pubmed 22498212
  • Department of Radiation Oncology, Brigham and Women's Hospital and Dana Farber Cancer Institute, Boston, MA 02115, USA. · Pubmed 22112793
  • Department of Radiation Oncology, Dana Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02215, USA. · Pubmed 21708431
2011
  • Brigham and Women's Hospital, Boston, MA 02115, USA. · Pubmed 22042952
  • Lank Center for Genitourinary Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, 44 Binney St., Boston, MA 02115, USA. · Pubmed 21958520
  • Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02215, USA. · Pubmed 21900597
  • Department of Medical Oncology and Cancer Vaccine Center, Dana-Farber Cancer Institute, Boston, MA 02215, USA. · Pubmed 21700764
  • Dana-Farber Cancer Institute, Harvard Medical School, Dana 710B, 44 Binney St., Boston, MA 02115, USA. · Pubmed 21606417
  • Department of Epidemiology, Harvard School of Public Health, 677 Huntington Ave, Boston, MA 02115, USA. · Pubmed 21537050
  • Department of Nutrition, Harvard School of Public Health, 655 Huntington Ave, Boston, MA 02115, USA. · Pubmed 21537045
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA. · Pubmed 21367958
  • The Broad Institute of Harvard and MIT, Cambridge, Massachusetts 02142, USA. · Pubmed 21307934
  • Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts 02115, USA. · Pubmed 21135144
  • Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA. · Pubmed 20862742
  • Department of Radiation Oncology, Dana Farber Cancer Institute and Brigham and Women's Hospital, Boston, MA 02115, USA. · Pubmed 20605366
  • Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. · Pubmed 20477822
2010
  • Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA. · Pubmed 21121759
  • Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA. · Pubmed 21119084
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America. · Pubmed 21085629
  • Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA. · Pubmed 20978177
  • Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts 02115, USA. · Pubmed 20855462
  • Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts 02115, USA. · Pubmed 20615892
  • Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115, USA. · Pubmed 20424130
  • Laboratory of Nanomedicine & Biomaterials, Department of Anesthesia, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA. · Pubmed 20394530
  • Department of Pathology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115, USA. · Pubmed 20388772
  • Department of Radiation Oncology, Dana Farber Cancer Institute and Brigham and Women's Hospital, Boston, Massachusetts 02115, USA. · Pubmed 19957321
  • Department of Radiation Oncology, Dana Farber Cancer Institute and Brigham and Women's Hospital, Boston, Massachusetts 02115, USA. · Pubmed 19864082
  • Lank Center for Genitourinary Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02115, USA. · Pubmed 19863532
  • Harvard Radiation Oncology Program, Department of Radiation Oncology, Brigham and Women's Hospital, Boston, MA 02115, USA. · Pubmed 19395186
2009
  • Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA 02115, USA. · Pubmed 19887483
  • Division of Hematology/Oncology, Massachusetts General Hospital, Boston, MA 02114, USA. · Pubmed 19403935
  • Harvard Radiation Oncology Program, Harvard Medical School, Boston, MA, USA. · Pubmed 19858385
  • Dana-Farber Cancer Institute, Boston, MA, USA. · Pubmed 19815488
  • Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02115, USA. · Pubmed 19632176
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA. · Pubmed 19549893
  • Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA. · Pubmed 19431146
  • Department of Radiation Oncology, Brigham and Women's Hospital and Dana Farber Cancer Institute, Boston, MA 02215, USA. · Pubmed 19395184
  • Department of Epidemiology, Harvard School of Public Health, Harvard University, Cambridge, Massachusetts, USA. · Pubmed 19366828
  • Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02115, USA. · Pubmed 19351832
  • Dana-Farber Cancer Institute/Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA. · Pubmed 19152438
2008
  • Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA. · Pubmed 18399827
  • Department of Radiation Oncology, Brigham and Women's Hospital, Boston, Massachusetts 02215, USA. · Pubmed 18291508
  • Department of Radiation Oncology, Brigham and Women's Hospital and Dana Farber Cancer Institute, Boston, MA 02215, USA. · Pubmed 18980297
  • Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115, USA. · Pubmed 18827812
  • Laboratory of Nanomedicine and Biomaterials, Department of Anesthesia, Brigham and Women's Hospital and Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA. · Pubmed 18613203
  • Channing Laboratory, Brigham and Women's Hospital, Boston, MA 02115, USA. · Pubmed 18583469
  • Department of Radiation, Brigham and Women's Hospital and Dana Farber Cancer Institute, Boston, MA 02215, USA. · Pubmed 18565884
  • Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA. · Pubmed 18505969
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA. · Pubmed 18302198
  • Harvard Medical School, Dana Farber Cancer Institute, Boston, Massachusetts 02115, USA. · Pubmed 18293426
  • Dana-Farber Cancer Institute, Dana 710-C, 44 Binney St, Boston, MA 02115, USA. · Pubmed 18281655
  • Department of Radiation Oncology, Brigham and Women's Hospital and Dana Farber Cancer Institute, Boston, Massachusetts 02115, USA. · Pubmed 18212313
  • Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, 181 Longwood Avenue, Boston, MA 02115, USA. · Pubmed 18199732
  • Lank Center for Genitourinary Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02115, USA. · Pubmed 18184327
2007
  • Harvard Medical School, Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. · Pubmed 17396482
  • Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, 44 Binney Street, Boston, MA 02115, USA. · Pubmed 17509304
  • Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, 181 Longwood Avenue, Boston, MA 02115, USA. · Pubmed 18006911
  • Laboratory of Nanomedicine and Biomaterials, Department of Anesthesiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA. · Pubmed 17854227
  • Diana-Farber Cancer Institute, Center for Genitourinary Oncology, Massachusetts General Hospital, Boston, MA, USA. · Pubmed 17669139
  • Departments of Radiation Oncology and Medicine, Cardiovascular Division, Brigham and Women's Hospital and Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA. · Pubmed 17557956
  • Lank Center for Genitourinary Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA. · Pubmed 17542988
  • Department of Biostatistics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Pubmed 17459967
  • Division of Hematology and Oncology and Endocrine Unit, Massachusetts General Hospital, Boston, MA 02114, USA. · Pubmed 17369566
  • Department of Pathology, Brigham and Women's Hospital, Boston, MA 02115-6110, USA. · Pubmed 17237811
Probable:    Memorial Sloan-Kettering Cancer Center   Contact    
2017
  • Dana-Farber Cancer Institute, Boston, Massachusetts. · University of Washington, Seattle, Washington. · Beth Israel Deaconess Medical Center, Boston, Massachusetts. · Veterans Affairs Puget Sound Health Care System, Seattle, Washington. · Beilinson Hospital, Petah Tikva, Israel. · McMaster University, Ontario, Canada. · Memorial Sloan Kettering Cancer Center, New York, New York. · Dana-Farber Cancer Institute, Boston, Massachusetts. · Pubmed 27683182
  • Division of Urology, Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America. · Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, United States of America. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America. · Pubmed 28886115
  • Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland. · Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts. · Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 28762529
  • Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts. · Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center, Tampa, Florida. · Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. · Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Statistics, Ohio State University, Columbus, Ohio. · Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts. · Department of Epidemiology, Boston University School of Public Health, Boston, Massachusetts. · Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, Massachusetts. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Histopathology, St. James's Hospital and Trinity College Dublin Medical School, Dublin, Ireland. · Koch Institute for Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts. · Department of Nutrition, Harvard T. H. Chan School of Public Health, Boston, Massachusetts. · Pubmed 28700821
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Surgery, Division of Urology, Brigham and Women's Hospital, Boston, Massachusetts. · Division of Population Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Physics of Complex Systems Eotvos Lorand University, Budapest, Hungary. · Department of Medicine, Tulane Cancer Center, New Orleans, Louisiana. · Department of Pediatrics, Boston Children's Hospital, Boston, Massachusetts. · Department of Medicine, Division of Hematology and Oncology, Tisch Cancer Institute, New York, New York. · Department of Medicine, Memorial Sloan Kettering Cancer Institute, New York, New York. · Pubmed 28608931
  • Department of Medicine, University of Washington, Seattle, Washington. · Department of Pathology, University of Washington, Seattle, Washington. · Princess Margaret Cancer Centre, Toronto, Canada. · Department of Urologic Sciences, University of British Columbia, Vancouver, Canada. · Beth Israel Deaconess Medical Center, Boston, Massachusetts. · Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, Washington. · Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington. · BC Cancer Agency and University of British Columbia, Vancouver, Canada. · Department of Urology, University of Washington, Seattle, Washington. · Department of Urology, Emory University, Atlanta, Georgia. · Medivation, Inc., San Francisco, California. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Memorial Sloan Kettering Cancer Center, New York, New York. · Geriatric Research, Education and Clinical Center, VA Puget Sound Health Care System, and Department of Medicine, Division of Gerontology & Geriatric Medicine, University of Washington, Seattle, Washington. · Department of Medicine, University of Washington, Seattle, Washington. · Brigham and Women's Hospital, Boston, Massachusetts. · Astellas Pharma, Inc., Northbrook, Illinois. · Pubmed 28151719
  • Harvard Radiation Oncology Program, Harvard Medical School, Boston, MA, USA. · Department of Statistics, University of Connecticut, Storrs, CT, USA. · Department of Radiation Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, MA, USA. · Department of Pathology, Miami Baptist Hospital, Miami, FL, USA. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Pubmed 28117382
  • Harvard Radiation Oncology Program, Brigham and Women's Hospital, Boston, Massachusetts2Department of Radiation Oncology, Brigham and Women's Hospital, Boston, Massachusetts3Dana Farber Cancer Institute, Boston, Massachusetts. · Department of Statistics, University of Connecticut, Storrs, Connecticut. · Department of Radiation Oncology, Brigham and Women's Hospital, Boston, Massachusetts3Dana Farber Cancer Institute, Boston, Massachusetts. · Department of Pathology, Baptist Hospital, Miami, Florida. · Department of Medicine, Memorial Sloan Kettering Institute, New York, New York. · Pubmed 28097317
  • Department of Radiation Oncology, Brigham and Women's Hospital, Boston, MA, USA. · Department of Statistics, University of Connecticut, Storrs, CT, USA. · Department of Pathology, Miami Baptist Hospital, Miami, FL, USA. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Pubmed 27824043
  • Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Urology and Medicine, Tulane University School of Medicine, New Orleans, Los Angeles. · Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 27489290
2016
  • Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Pubmed 27502737
  • Perini Family Survivors' Center, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, USA; Department of Pediatrics, Harvard Medical School, 25 Shattuck Street, Boston, MA, USA. Electronic address: · Perini Family Survivors' Center, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, USA; Department of Pediatrics, Harvard Medical School, 25 Shattuck Street, Boston, MA, USA. Electronic address: · Perini Family Survivors' Center, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, USA; Department of Pediatrics, Harvard Medical School, 25 Shattuck Street, Boston, MA, USA. Electronic address: · Department of Urology, Weill Cornell Medical Center, 1300 York Avenue, New York, NY, USA. Electronic address: · Department of Medicine, Memorial Sloan Kettering Cancer Center, 600 Third Avenue, New York, NY, USA. Electronic address: · Perini Family Survivors' Center, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, USA; Department of Pediatrics, Harvard Medical School, 25 Shattuck Street, Boston, MA, USA. Electronic address: · Pubmed 27439668
  • Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. · Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. · Interne de Paris, Urology, Paris, France. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Cancer Biology, Cleveland Clinic, Cleveland, Ohio. · Pubmed 27325180
  • Departments Of Epidemiology & Biostatistics and Urology, University of CA San Francisco. · SWOG Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, WA. · Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston MA. · Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital/Harvard Medical School, Boston, MA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston MA. · Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan Cancer Center, Michigan. · Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH. · The Cancer Therapy and Research Center, University of Texas Health Science Center at San Antonio, San Antonio, TX. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 27197287
  • Department of Urology, Osaka Medical College, Osaka 569-8686, Japan; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065; · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215; · Department of Urology, Osaka Medical College, Osaka 569-8686, Japan; · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065; · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215; Harvard Medical School, Boston, MA 02215 · Pubmed 27185910
2017
  • Wanling Xie, Meredith M. Regan, and Christopher J. Sweeney, Dana-Farber Cancer Institute, Boston, MA; Marc Buyse, International Drug Development Institute; Bertrand Tombal, Université Catholique de Louvain, Louvain-la-Neuve; Laurence Collette, European Organisation for Research and Treatment of Cancer, Brussels, Belgium; Susan Halabi, Duke University Medical Center, Durham, NC; Philip W. Kantoff, Memorial Sloan Kettering Cancer Center, New York, NY; Oliver Sartor, Tulane Medical School, New Orleans, LA; Howard Soule, Prostate Cancer Foundation, Santa Monica; Howard M. Sandler, Cedars-Sinai Medical Center, Los Angeles, CA; Noel W. Clarke, The Christie NHS Foundation Trust, Manchester; Matthew R. Sydes, University College London, London, United Kingdom; James J. Dignam, University of Chicago, Chicago, IL; Karim Fizazi, Institut Gustave-Roussy, Villejuif, France; Wendy R. Paruleker, Canadian Cancer Trials Group, Kingston, Ontario, Canada; and Scott G. Williams, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Pubmed 28796587
2016
  • Howard I. Scher, Michael J. Morris, Dana E. Rathkopf, and Susan F. Slovin, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College; David Nanus, NewYork Presbyterian Weill Cornell Medical Center; Lawrence W. Schwartz, NewYork Presbyterian Columbia University Medical Center, New York, NY; Walter M. Stadler, University of Chicago Medicine, Chicago, IL; Celestina Higano and Peter S. Nelson, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, WA; Ethan Basch, University of North Carolina at Chapel Hill, Chapel Hill, NC; Emmanual S. Antonarakis and Michael A. Carducci, Johns Hopkins University School of Medicine, Baltimore, MD; Tomasz M. Beer, Oregon Health and Science University, Portland, OR; Paul G. Corn and Christopher Logothetis, MD Anderson Cancer Center, Houston, TX; Robert Dreicer, University of Virginia School of Medicine, Charlottesville, VA; Daniel J. George, Susan Halabi, and Andrew J. Armstrong, Duke University and Duke Cancer Institute, Durham, NC; Elisabeth I. Heath, Wayne State University Karmanos Cancer Institute, Detroit; and Maha Hussain, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; Wm. Kevin Kelly, Sidney Kimmel School of Medicine at Thomas Jefferson University, Philadelphia, PA; Glenn Liu and George Wilding, University of Wisconsin Carbone Cancer Center, Madison, WI; Mark N. Stein, The Cancer Institute of New Jersey, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, New Brunswick, NJ; Charles S. Ryan and Eric J. Small, University of California Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Oliver Sartor, Tulane School of Medicine, New Orleans, LA; Matthew Raymond Smith, Massachusetts General Hospital Cancer Center and Harvard Medical School; Mary-Ellen Taplin and Philip W. Kantoff, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, Franc · Pubmed 26903579
  • Rana R. McKay, Lillian Werner, Christopher J. Sweeney, Philip W. Kantoff, and Mary-Ellen Taplin, Dana-Farber Cancer Institute, Boston; Robert W. Ross, Bluebird Bio, Cambridge, MA; Amado J. Zurita and Hai T. Tran, MD Anderson Cancer Center, Houston, TX; Justine Y. Bruce, University of Wisconsin Carbone Cancer Center, Madison, WI; Michael A. Carducci, Johns Hopkins University; Arif Hussain, Greenebaum Cancer Center, Baltimore, MD; Mark N. Stein, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ; Elisabeth I. Heath, Karmanos Cancer Institute, Detroit, MI; and Philip W. Kantoff and Susan F. Slovin, Memorial Sloan Kettering Cancer Center, New York, NY. · Rana R. McKay, Lillian Werner, Christopher J. Sweeney, Philip W. Kantoff, and Mary-Ellen Taplin, Dana-Farber Cancer Institute, Boston; Robert W. Ross, Bluebird Bio, Cambridge, MA; Amado J. Zurita and Hai T. Tran, MD Anderson Cancer Center, Houston, TX; Justine Y. Bruce, University of Wisconsin Carbone Cancer Center, Madison, WI; Michael A. Carducci, Johns Hopkins University; Arif Hussain, Greenebaum Cancer Center, Baltimore, MD; Mark N. Stein, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ; Elisabeth I. Heath, Karmanos Cancer Institute, Detroit, MI; and Philip W. Kantoff and Susan F. Slovin, Memorial Sloan Kettering Cancer Center, New York, NY. · Pubmed 27044933
  • Nicholas J. Giacalone, Marian Loffredo, and Anthony V. D'Amico, Brigham and Women's Hospital/Dana-Farber Cancer Institute; Nicholas J. Giacalone, Harvard Radiation Oncology Program, Boston, MA; Jing Wu and Ming-Hui Chen, University of Connecticut, Storrs, CT; Andrew Renshaw, Miami Baptist Hospital, Miami, FL; and Philip W. Kantoff, Memorial Sloan Kettering Cancer Center, New York, NY. · Pubmed 27601545
  • From the University of Washington (C.C.P., M. Beightol, C.M., B.N., H.H.C., B.M., T.W., S. Casadei, P.S.N.) and Fred Hutchinson Cancer Research Center (N.D.S., R.G., P.S.N.) - both in Seattle; the Institute of Cancer Research and Royal Marsden Hospital, London (J.M., S. Carreira, R.E., J.B.); Memorial Sloan Kettering Cancer Center (M.F.W., W.A., M. Berger, L.Z., A.Z., J. Vijai, H.I.S., C.S., N.S., P.W.K., D.S., M.R., K.O.), Weill Cornell Medical College (H.B., O.E., M.A.R.), and the Prostate Cancer Clinical Trials Consortium (J. Vinson, J.F.) - all in New York; the University of Michigan, Ann Arbor (D.R., R.L., M.H., A.C.); Howard Hughes Medical Institute, Chevy Chase, MD (A.C., C.S.); and Dana-Farber Cancer Institute, Boston (A.G., L.G., M.-E.T., S.A., G.C.H., E.M.V.A.). · Pubmed 27433846
2015
  • Michael J. Morris, Steven M. Larson, and Howard I. Scher, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY; Arturo Molina, Thian Kheoh, Shannon L. Matheny, Vahid Naini, and Thomas W. Griffin, Janssen Research & Development, Los Angeles; Eric J. Small and Charles J. Ryan, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA; Johann S. de Bono, Institute for Cancer Research and Royal Marsden Hospital, Sutton, United Kingdom; Christopher J. Logothetis, MD Anderson Cancer Center, Houston, TX; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, France; Paul de Souza, University of Western Sydney School of Medicine, Ingham Institute, Liverpool, New South Wales, Australia; Philip W. Kantoff, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; Celestia S. Higano, University of Washington, Seattle, WA; Jinhui Li, Janssen Research & Development, Raritan, NJ; and Tomasz Burzykowski, International Drug Development Institute, Louvain-la-Neuve, Belgium. · Michael J. Morris, Steven M. Larson, and Howard I. Scher, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY; Arturo Molina, Thian Kheoh, Shannon L. Matheny, Vahid Naini, and Thomas W. Griffin, Janssen Research & Development, Los Angeles; Eric J. Small and Charles J. Ryan, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA; Johann S. de Bono, Institute for Cancer Research and Royal Marsden Hospital, Sutton, United Kingdom; Christopher J. Logothetis, MD Anderson Cancer Center, Houston, TX; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, France; Paul de Souza, University of Western Sydney School of Medicine, Ingham Institute, Liverpool, New South Wales, Australia; Philip W. Kantoff, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; Celestia S. Higano, University of Washington, Seattle, WA; Jinhui Li, Janssen Research & Development, Raritan, NJ; and Tomasz Burzykowski, International Drug Development Institute, Louvain-la-Neuve, Belgium. · Pubmed 25624432
2013
  • From 1Roswell Park Cancer Institute; 2Dana-Farber/Brigham and Women's Cancer Center; 3Duke Cancer Institute; 4The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute; 5Huntsman Cancer Institute at the University of Utah; 6Memorial Sloan-Kettering Cancer Center; 7Fred & Pamela Buffett Cancer Center at The Nebraska Medical Center; 8Prostate Health Education Network; 9University of Washington/Seattle Cancer Care Alliance; 10Fox Chase Cancer Center; 11City of Hope Comprehensive Cancer Center; 12Massachusetts General Hospital Cancer Center; 13Robert H. Lurie Comprehensive Cancer Center of Northwestern University; 14Vanderbilt-Ingram Cancer Center; 15University of Michigan Comprehensive Cancer Center; 16Moffitt Cancer Center; 17St. Jude Children's Research Hospital/The University of Tennessee Health Science Center; 18UCSF Helen Diller Family Comprehensive Cancer Center; 19The University of Texas MD Anderson Cancer Center; 20Patient Advocate; 21Stanford Cancer Institute; 22Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; 23The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; and 24National Comprehensive Cancer Network. · Pubmed 24335682
2012
  • Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Pubmed 22802323
2009
  • Genitourinary Oncology Service, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA. · Pubmed 19213669
2008
  • Genitourinary Oncology Service, Department of Medicine, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10065, USA. · Pubmed 18309951
Probable:    Miscellaneous institutions in New York City      
2016
  • Shanghai Key Laboratory of Tuberculosis, Shanghai Pulmonary Hospital, Shanghai 200433, China. · Department of Bioinformatics, School of Life Sciences and Technology, Tongji University, Shanghai 200092, China. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA. · Harvard Medical School, Boston, Massachusetts 02215, USA. · Department of Pathology, University of Massachusetts Medical School, Worcester, Massachusetts 01655, USA. · Department of Molecular and Cellular Biology, Harvard University, Cambridge, Massachusetts 02138, USA. · Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, Massachusetts 02138, USA. · Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, Massachusetts 02142, USA. · Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA. · Department of Pathology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA. · Department of Bioinformatics and Computational Biology, Division of Quantitative Sciences, University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. · Department of Medicine Memorial Sloan Kettering Cancer Center 1275 York Avenue, New York, New York 10065, USA. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute and Harvard School of Public Health, Boston, Massachusetts 02215, USA. · Pubmed 26975529
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 208 total) written by Phillip W. Kantoff about Prostatic Neoplasms:

  • The ABC model of prostate cancer: A conceptual framework for the design and interpretation of prognostic studies. 2017
  • A Phase II Trial of Abiraterone Combined with Dutasteride for Men with Metastatic Castration-Resistant Prostate Cancer. 2017
  • Androgen receptor-mediated downregulation of microRNA-221 and -222 in castration-resistant prostate cancer. 2017
  • Metastasis-Free Survival Is a Strong Surrogate of Overall Survival in Localized Prostate Cancer. 2017
  • The impact of statin use on the efficacy of abiraterone acetate in patients with castration-resistant prostate cancer. 2017
  • Gene expression profiling of prostate tissue identifies chromatin regulation as a potential link between obesity and lethal prostate cancer. 2017
  • The association between germline BRCA2 variants and sensitivity to platinum-based chemotherapy among men with metastatic prostate cancer. 2017
  • Neoadjuvant Enzalutamide Prior to Prostatectomy. 2017
  • The impact of comorbidity and PSA doubling time on the risk of death in men experiencing PSA failure following radiation therapy with or with androgen deprivation therapy for unfavorable-risk prostate cancer. 2017
  • Surrogate End Points for All-Cause Mortality in Men With Localized Unfavorable-Risk Prostate Cancer Treated With Radiation Therapy vs Radiation Therapy Plus Androgen Deprivation Therapy: A Secondary Analysis of a Randomized Clinical Trial. 2017
Show List of Full Article Records
Google Searches

Learn more about Phillip W. Kantoff using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Harvard University
Memorial Sloan-Kettering Cancer Center
Miscellaneous institutions in New York City
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Harvard University
2017
  • Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts. · Clinical Epidemiology Unit, Department of Medicine Solna, Karolinska Institute, Stockholm, Sweden. · Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center, Tampa, Florida. · Clinical Epidemiology and Biostatistics, Faculty of Medicine and Health, Örebro University, Örebro, Sweden. · Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden. · Faculty of Life Sciences and Medicine, King's College London, London, United Kingdom. · Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, Massachusetts. · Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Department of Epidemiology, Boston University School of Public Health, Boston, Massachusetts. · Pubmed 28152172
  • Dana-Farber Cancer Institute, Boston, Massachusetts. · University of Washington, Seattle, Washington. · Beth Israel Deaconess Medical Center, Boston, Massachusetts. · Veterans Affairs Puget Sound Health Care System, Seattle, Washington. · Beilinson Hospital, Petah Tikva, Israel. · McMaster University, Ontario, Canada. · Memorial Sloan Kettering Cancer Center, New York, New York. · Dana-Farber Cancer Institute, Boston, Massachusetts. · Pubmed 27683182
  • Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland. · Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts. · Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 28762529
  • Department of Medicine, University of Washington, Seattle, Washington. · Department of Pathology, University of Washington, Seattle, Washington. · Princess Margaret Cancer Centre, Toronto, Canada. · Department of Urologic Sciences, University of British Columbia, Vancouver, Canada. · Beth Israel Deaconess Medical Center, Boston, Massachusetts. · Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, Washington. · Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington. · BC Cancer Agency and University of British Columbia, Vancouver, Canada. · Department of Urology, University of Washington, Seattle, Washington. · Department of Urology, Emory University, Atlanta, Georgia. · Medivation, Inc., San Francisco, California. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Memorial Sloan Kettering Cancer Center, New York, New York. · Geriatric Research, Education and Clinical Center, VA Puget Sound Health Care System, and Department of Medicine, Division of Gerontology & Geriatric Medicine, University of Washington, Seattle, Washington. · Department of Medicine, University of Washington, Seattle, Washington. · Brigham and Women's Hospital, Boston, Massachusetts. · Astellas Pharma, Inc., Northbrook, Illinois. · Pubmed 28151719
  • Dana-Farber Cancer Institute, Boston, Massachusetts. · Harvard Medical School, Boston, Massachusetts. · Broad Institute of Harvard and MIT, Cambridge, Massachusetts. · Brigham and Women's Hospital, Boston, Massachusetts. · Dana-Farber Cancer Institute, Boston, Massachusetts. · Pubmed 27899381
  • Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Urology and Medicine, Tulane University School of Medicine, New Orleans, Los Angeles. · Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 27489290
2016
  • Department of Medical Oncology, BC Cancer Agency, Vancouver, Canada · Janssen Research & Development, San Diego. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco. · Janssen Research & Development, Menlo Park. · Department of Solid Tumor Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston. · Comprehensive Cancer Centers of Nevada, Las Vegas. · Department of Oncology and Internal Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, USA. · Groupe Uro-Genitologie, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Johnson & Johnson Medical China, Shanghai, China. · Department of Medical Oncology, BC Cancer Agency, Vancouver, Canada. · Tom Baker Cancer Center and University of Calgary, Calgary. · Department of Medical Oncology, Princess Margaret Hospital and University of Toronto, Toronto, Canada. · Drug Development Unit, Division of Cancer Therapeutics/Clinical Studies, The Institute for Cancer Research and Royal Marsden Hospital, Sutton, UK. · Genitourinary Oncology Service, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, USA. · Pubmed 26685010
  • The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins Medical Institutions, Baltimore, Maryland. · The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins Medical Institutions, Baltimore, Maryland Department of Medical Oncology, Johns Hopkins Medical Institutions, Baltimore, Maryland The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins Medical Institutions, Baltimore, Maryland; and. · Department of Medical Oncology, Johns Hopkins Medical Institutions, Baltimore, Maryland. · The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins Medical Institutions, Baltimore, Maryland; and. · Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins Medical Institutions, Baltimore, Maryland · Pubmed 26493203
  • Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Pubmed 27502737
  • Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. · Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. · Interne de Paris, Urology, Paris, France. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Cancer Biology, Cleveland Clinic, Cleveland, Ohio. · Pubmed 27325180
  • Departments Of Epidemiology & Biostatistics and Urology, University of CA San Francisco. · SWOG Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, WA. · Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston MA. · Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital/Harvard Medical School, Boston, MA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston MA. · Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan Cancer Center, Michigan. · Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH. · The Cancer Therapy and Research Center, University of Texas Health Science Center at San Antonio, San Antonio, TX. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 27197287
  • Department of Urology, Osaka Medical College, Osaka 569-8686, Japan; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065; · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215; · Department of Urology, Osaka Medical College, Osaka 569-8686, Japan; · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065; · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215; Harvard Medical School, Boston, MA 02215 · Pubmed 27185910
  • Shanghai Key Laboratory of Tuberculosis, Shanghai Pulmonary Hospital, Shanghai 200433, China. · Department of Bioinformatics, School of Life Sciences and Technology, Tongji University, Shanghai 200092, China. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA. · Harvard Medical School, Boston, Massachusetts 02215, USA. · Department of Pathology, University of Massachusetts Medical School, Worcester, Massachusetts 01655, USA. · Department of Molecular and Cellular Biology, Harvard University, Cambridge, Massachusetts 02138, USA. · Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, Massachusetts 02138, USA. · Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, Massachusetts 02142, USA. · Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA. · Department of Pathology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA. · Department of Bioinformatics and Computational Biology, Division of Quantitative Sciences, University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. · Department of Medicine Memorial Sloan Kettering Cancer Center 1275 York Avenue, New York, New York 10065, USA. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute and Harvard School of Public Health, Boston, Massachusetts 02215, USA. · Pubmed 26975529
  • Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. · Department of Epidemiology and Biostatistics and Urology, University of California, San Francisco, California. · Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts. · Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts. · Pubmed 26847995
  • Harvard-MIT Division of Health Sciences and Technology, Harvard Medical School, Boston, MA. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. · Gelb Center for Translational Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. · Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. · Department of Radiation Oncology, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. Electronic address: · Pubmed 26778006
  • Department of Radiology, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA. Electronic address: · Department of Radiology, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA. · Harvard Medical School, Boston, MA, USA; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. · Pubmed 26767544
  • Department of Pathology, University of Michigan Health System, Ann Arbor, MI, USA; Comprehensive Cancer Center, University of Michigan Health System, Ann Arbor, MI, USA; Michigan Center for Translational Pathology, Ann Arbor, MI, USA. Electronic address: · Department of Pathology, University of Michigan Health System, Ann Arbor, MI, USA. · Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, MA, USA. · Michigan Center for Translational Pathology, Ann Arbor, MI, USA. · Comprehensive Cancer Center, University of Michigan Health System, Ann Arbor, MI, USA; Michigan Center for Translational Pathology, Ann Arbor, MI, USA; Department of Radiation Oncology, University of Michigan Health System, Ann Arbor, MI, USA. · Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. · Department of Pathology, University of Michigan Health System, Ann Arbor, MI, USA; Comprehensive Cancer Center, University of Michigan Health System, Ann Arbor, MI, USA; Michigan Center for Translational Pathology, Ann Arbor, MI, USA; Howard Hughes Medical Institute, Ann Arbor, MI, USA. Electronic address: · Pubmed 26724257
  • All authors: Dana-Farber Cancer Institute, Boston, MA. · All authors: Dana-Farber Cancer Institute, Boston, MA. · Pubmed 26668348
  • Center for Surgery and Public Health, Division of Urologic Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts2Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Center for Surgery and Public Health, Division of Urologic Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. · Dana-Farber Cancer Institute, Department of Medical Oncology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. · Vattikuti Urology Institute, Henry Ford Health System, Detroit, Michigan. · Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Center for Community-Based Research, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. · Dana-Farber Cancer Institute, Department of Radiation Oncology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. · Pubmed 26502115
  • Department of Radiation Oncology, Dana Farber Cancer Institute, Boston, Massachusetts. · Department of Statistics, University of Connecticut, Storrs. · Department of Medicine, Dana Farber Cancer Institute, Boston, Massachusetts. · Pubmed 26954420
2015
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. Electronic address: · Pubmed 25577717
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA. · Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA. · Channing Laboratory, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · Pubmed 25531313
  • Centers for Cancer Pharmacology and Excellence of Environmental Toxicology (CEET), Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104-6160, USA. · Fred Hutchinson Cancer Center, University of Washington, Seattle, WA 98109, USA. · Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA. · Dana Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA. · Centers for Cancer Pharmacology and Excellence of Environmental Toxicology (CEET), Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104-6160, USA. Electronic address: · Pubmed 25514466
  • Department of Radiation Oncology, Dana-Farber/Brigham and Women's Cancer Center, Boston, MA, USA. Electronic address: · Department of Medicine, University Health Network, Toronto, Canada. · Section on Men's Health, Aging and Metabolism, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · Department of Radiation Oncology, Dana-Farber/Brigham and Women's Cancer Center, Boston, MA, USA. · Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · Division of General Internal Medicine, Department of Medicine, Brigham and Women's Hospital, and Department of Health Care Policy, Harvard Medical School, Boston, MA, USA. · Department of Urologic Surgery and the Center for Surgical Quality and Outcomes Research, Vanderbilt University, and the VA Tennessee Valley Geriatric Research, Education, and Clinical Center, Nashville, TN, USA. · Academic Urology Unit, Department of Oncology, Royal Hallamshire Hospital, University of Sheffield, Sheffield, UK. · Division of Urology, Cliniques Universitaires Saint Luc, Université Catholique de Louvain, Brussels, Belgium. · Department of Hematology-Oncology, Massachusetts General Hospital Cancer Center, Boston, MA, USA. · Pubmed 25097095
  • Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Genitourinary Medical Oncology, Beth Israel Deaconess Medical Center, Boston, Massachusetts. · Genitourinary Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York. · Medical Oncology/Hematology Program, Greenebaum Cancer Center, Baltimore, Maryland. · Pubmed 25903013
  • Dendreon Corporation, Seattle, Washington. · Mount Sinai School of Medicine, New York, New York. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · University of Washington School of Medicine and Fred Hutchinson Cancer Research Center, Seattle, Washington. · University of California, San Francisco, San Francisco, California. · Indiana University Simon Cancer Center, Indianapolis, Indiana. · Dendreon Corporation, Seattle, Washington. · Johns Hopkins University School of Medicine, the Brady Urological Institute, Baltimore, Maryland. · Pubmed 25649018
  • Medical Oncology, Dana-Farber Cancer Institute and Internal Medicine, Harvard Medical School, Boston, MA. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA. · Department of Imaging, Dana-Farber Cancer Institute, Department of Radiology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA. · Knight Cancer Institute at Oregon Health and Science University, Portland, OR. · Medical Oncology, Dana-Farber Cancer Institute and Internal Medicine, Harvard Medical School, Boston, MA; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA. · Medical Oncology, Dana-Farber Cancer Institute and Internal Medicine, Harvard Medical School, Boston, MA. Electronic address: · Pubmed 25450031
  • Center for Surgery and Public Health, Brigham and Women's Hospital, Boston, Massachusetts. · VUI Center for Outcomes Research, Analytics and Evaluation, Henry Ford Health System, Detroit, Michigan. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Pubmed 26575066
  • Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts. · Department of Epidemiology, University of Florida, Gainesville, Florida. · Department of Radiation Oncology, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Boston, Massachusetts. · Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts. · Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, Massachusetts. · Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Pubmed 26469352
  • Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA. · Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. · The Eli and Edythe L. Broad Institute, Cambridge, Massachusetts, USA. · Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA. · Pubmed 26457646
  • Department of Radiation Oncology, Brigham and Women's Hospital, Boston, Massachusetts. · Department of Statistics, University of Connecticut, Storrs. · Department of Pathology, Miami Baptist Hospital, Miami, Florida. · Department of Medicine, Dana Farber Cancer Institute, Boston, Massachusetts. · Pubmed 26393854
  • Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Pubmed 26289068
  • Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Gelb Center for Translational Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Gelb Center for Translational Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts4Department of Urology, Shanghai Jiao Tong University School of Medicine, Xinhua Hospital, Shanghai, China. · Apple Tree Partners, New York, New York. · Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts. · Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts2Gelb Center for Translational Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Pubmed 26181260
  • Department of Radiation Oncology, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts. · Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts. Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. · Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts. Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · School of Health and Medical Sciences, Örebro University; and Department of Urology, Örebro University Hospital, Örebro, Sweden. · Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts. Pathology Unit, Addarii Institute, S Orsola-Malpighi Hospital, Bologna, Italy. · Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts. Department of Pathology, Trinity College, Dublin, Ireland. · Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts. Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. Broad Institute of Harvard and MIT, Cambridge, Massachusetts. Division of Cancer Studies, King's College London, London, United Kingdom. · Pubmed 26124442
  • Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA 02142, USA. · Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA. · Department of Pathology and Laboratory Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; Institute for Precision Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; New York Presbyterian Hospital, New York, NY 10021, USA; Meyer Cancer, Weill Medical College of Cornell University, New York, NY 10021, USA. · Computational Biology Program, Public Health Sciences Division and Basic Science Division, Fred Hutchinson Cancer Center, University of Washington, Seattle, WA 98109, USA; Department of Medicine and VAPSHCS, University of Washington, Seattle, WA 98109, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA. · Department of Laboratory Medicine, University of Washington, Seattle, WA 98195, USA. · Cancer Biomarkers Team, Division of Clinical Studies, The Institute of Cancer Research, London SM2 5NG, UK; Prostate Cancer Targeted Therapy Group and Drug Development Unit, The Royal Marsden NHS Foundation Trust, London SM2 5NG, UK. · Institute for Precision Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; New York Presbyterian Hospital, New York, NY 10021, USA; Department of Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; Meyer Cancer, Weill Medical College of Cornell University, New York, NY 10021, USA. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Genitourinary Oncology Service, Department of Medicine, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Computational Biology Program, Public Health Sciences Division and Basic Science Division, Fred Hutchinson Cancer Center, University of Washington, Seattle, WA 98109, USA. · Prostate Cancer Clinical Trials Consortium, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Howard Hughes Medical Institute, University of Michigan, Ann Arbor, MI 48109, USA. · Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, MI 48109, USA. · Department of Internal Medicine, Division of Hematology Oncology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Urology, University of Michigan Medical School, Ann Arbor, MI 48109, USA. · Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Radiation Oncology, University of Michigan Medical School, Ann Arbor, MI 48109, USA. · Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Urology, University of Michigan Medical School, Ann Arbor, MI 48109, USA. · Department of Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Genitourinary Oncology Service, Department of Medicine, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; Genitourinary Oncology Service, Department of Medicine, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Interventional Radiology, Department of Radiology Service, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA 02142, USA; Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Pathology, Brigham & Women's Hospital, Boston, MA 02115, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA 02215, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Pathology, Brigham & Women's Hospital, Boston, MA 02115, USA. · Division of Hematology-Oncology, Department of Medicine, Beth Israel Deaconess Cancer Center, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA. · Department of Musculoskeletal Radiology, Brigham and Women's Hospital, Boston, MA 02115, USA. · Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA 02142, USA. · Department of Medicine and VAPSHCS, University of Washington, Seattle, WA 98109, USA. · Department of Radiology, University of Washington, Seattle, WA 98109, USA. · Department of Pathology, University of Washington Medical Center, Seattle, WA 98109, USA. · Institute for Precision Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; Laboratory of Computational Oncology, CIBIO, Centre for Integrative Biology, University of Trento, 38123 Mattarello TN, Italy. · Institute for Precision Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; Division of Interventional Radiology, Department of Radiology, New York-Presbyterian Hospital/Weill Cornell Medical Center, New York, NY 10021, USA; Meyer Cancer, Weill Medical College of Cornell University, New York, NY 10021, USA. · Institute for Precision Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; Institute for Computational Biomedicine, Department of Physiology and Biophysics, Weill Medical College of Cornell University, New York, NY 10021, USA; Department of Physiology & Biophysics, Weill Medical College of Cornell University, New York, NY 10021, USA. · Institute for Computational Biomedicine, Department of Physiology and Biophysics, Weill Medical College of Cornell University, New York, NY 10021, USA. · Department of Pathology and Laboratory Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; Institute for Precision Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; Institute for Computational Biomedicine, Department of Physiology and Biophysics, Weill Medical College of Cornell University, New York, NY 10021, USA; Meyer Cancer, Weill Medical College of Cornell University, New York, NY 10021, USA. · Department of Oncology, Wayne State University School of Medicine, Detroit, MI 48201, USA; Molecular Therapeutics Program, Barbara Ann Karmanos Cancer Institute, Detroit, MI 48201, USA. · The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins School of Medicine, Baltimore, MD 21205, USA. · Department of Medicine and VAPSHCS, University of Washington, Seattle, WA 98109, USA; Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA; Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA; Meyer Cancer, Weill Medical College of Cornell University, New York, NY 10021, USA. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Howard Hughes Medical Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. Electronic address: · Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Urology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Howard Hughes Medical Institute, University of Michigan, Ann Arbor, MI 48109, USA. Electronic address: · Pubmed 26000489
  • Radiation Oncology, Brigham and Women's Hospital and Dana-Farber Cancer Institute, Boston, MA (P.L.N., P.L.G., A.H.). · Department of Pathology, Brigham and Women's Hospital, Boston, MA (P.J.). · Endocrinology, Brigham and Women's Hospital, Boston, MA (S.B.). · Cardiovascular Division, Brigham and Women's Hospital, Boston, MA (J.P.Z., J.M., S.K., J.A.B.). · Medical Oncology, Dana-Farber Cancer Institute, Boston, MA (P.W.K.). · Pubmed 25896892
  • Department of Medical Oncology, and. · Department of Medical Oncology, and Broad Institute, Cambridge, Massachusetts. · Hematology-Oncology Division, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts. · Department of Medical Oncology, and Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. · Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada. Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada. · Division of Clinical Research, Fred Hutchinson Cancer Research Center and Department of Medicine, University of Washington School of Medicine, Seattle, Washington. · Department of Medical Oncology, and Broad Institute, Cambridge, Massachusetts. · Department of Medical Oncology, and · Pubmed 25808865
  • Metamark Genetics Inc., Cambridge, Massachusetts. · Department of Pathology and Molecular Medicine, Queen's University, Kingston, Ontario, Canada. · Department of Pathology, Yale University Medical School, New Haven, Connecticut. · Urology Austin, Austin, Texas. · Impacts Inc., Montreal, Quebec, Canada. · Dana-Farber Cancer Institute, Boston, Massachusetts. · Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, Ohio. · Department of Anatomic Pathology, Cleveland Clinic, Cleveland, Ohio. · Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada. · Department of Pathology, Urology and Oncology, Johns Hopkins Hospital, Baltimore, Maryland. · Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada. · Pubmed 25733599
  • Department of Radiation Oncology, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Boston, MA. Electronic address: · Department of Epidemiology, Harvard School of Public Health, Boston, MA. · Departments of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA. · Department of Epidemiology, Harvard School of Public Health, Boston, MA; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA. · Department of Radiation Oncology, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Boston, MA. · Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA. · Pubmed 25662905
  • Division of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York. Electronic address: · Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Department of Pathology, David Geffen School of Medicine at University of California-Los Angeles, Los Angeles, California. · Division of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York. · Pubmed 25623747
  • Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · University of Washington, Seattle, Washington. · University of Texas MD Anderson Cancer Center, Houston, Texas. · University of Washington, Seattle, Washington. Fred Hutchinson Cancer Research Center, Seattle, Washington. · Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Pubmed 25320358
  • Department of Radiation Oncology, Dana Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA. · Department of Statistics, University of Connecticut, Storrs, CT. · Department of Radiation Oncology, Boston Medical Center, Boston University School of Medicine, Boston, MA. · Department of Medical Oncology, Dana Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA. · Department of Radiation Oncology, Dana Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA. Electronic address: · Pubmed 25103271
2014
  • Department of Medicine, University of Wisconsin Carbone Cancer Center, Madison, Wisconsin. · Department of Urology, Indiana University Simon Cancer Center, Indianapolis, Indiana. · Department of Medicine, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, Washington. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco Comprehensive Cancer Center, San Francisco, California. · Department of Laboratory Medicine, University of Washington, Seattle, Washington. · Dendreon Corporation, Seattle, Washington. · Department of Solid Tumor Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio. · Pubmed 25189164
  • Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. · 1] Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada [2] Brigham and Women's Hospital, Boston, MA, USA. · Beth Israel Deaconess Medical Center, Boston, MA, USA. · 1] Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA, USA [2] Brigham and Women's Hospital, Boston, MA, USA. · Brigham and Women's Hospital, Boston, MA, USA. · Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA, USA. · Pubmed 25091040
  • Vattikuti Urology Institute Center for Outcomes Research, Analytics, and Evaluation, Henry Ford Health System, Detroit, Michigan. · Division of Urologic Surgery, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Vattikuti Urology Institute Center for Outcomes Research, Analytics, and Evaluation, Henry Ford Health System, Detroit, Michigan2Division of Urologic Surgery, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Boston, Massachusetts4Center for Sur. · Pubmed 25179266
  • Helen Diller Family Comprehensive Cancer Center, University of California at San Francisco, San Francisco, CA, USA. · Departments of Oncology and Urology, School of Medicine, University of Washington, Seattle, WA, USA. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Dendreon Corporation, Seattle, WA, USA. · Smilow Cancer Center, Yale University, New Haven, CT, USA. · Pubmed 24957547
  • Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts. · Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts. · Department of Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts. Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts. Department of Nutrition, Harvard School of Public Health, Boston, Massachusetts. Channing Division of Network Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. · Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts. Department of Biostatistics, Harvard School of Public Health, Boston, Massachusetts. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts. Channing Division of Network Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. · Pubmed 24925673
  • Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02115; · Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02115;Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215; · Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215;Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute and Harvard School of Public Health, Boston, MA 02115; and. · Hematology-Oncology Division, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02215. · Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02115; · Pubmed 24778216
  • 1] The Eli and Edythe L. Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA. [2] Dana-Farber Cancer Institute, Boston, Massachusetts, USA. [3] Harvard Medical School, Boston, Massachusetts, USA. [4]. · 1] The Eli and Edythe L. Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA. [2] Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA. [3]. · 1] The Eli and Edythe L. Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA. [2]. · 1] The Eli and Edythe L. Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA. [2] Dana-Farber Cancer Institute, Boston, Massachusetts, USA. [3] Harvard Medical School, Boston, Massachusetts, USA. · The Eli and Edythe L. Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA. · 1] The Eli and Edythe L. Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA. [2] Dana-Farber Cancer Institute, Boston, Massachusetts, USA. · Department of Chemistry and Chemical Biology, Harvard University, Cambridge, Massachusetts, USA. · Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA. · Brigham and Women's Hospital, Boston, Massachusetts, USA. · 1] Dana-Farber Cancer Institute, Boston, Massachusetts, USA. [2] Harvard Medical School, Boston, Massachusetts, USA. · Dana-Farber Cancer Institute, Boston, Massachusetts, USA. · Massachusetts General Hospital, Boston, Massachusetts, USA. · 1] Dana-Farber Cancer Institute, Boston, Massachusetts, USA. [2] Harvard Medical School, Boston, Massachusetts, USA. [3] Brigham and Women's Hospital, Boston, Massachusetts, USA. · 1] The Eli and Edythe L. Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA. [2] Dana-Farber Cancer Institute, Boston, Massachusetts, USA. [3] Harvard Medical School, Boston, Massachusetts, USA. [4] Brigham and Women's Hospital, Boston, Massachusetts, USA. · 1] The Eli and Edythe L. Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA. [2] Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA. [3] Howard Hughes Medical Institute, Chevy Chase, Maryland, USA. · 1] The Eli and Edythe L. Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA. [2] Dana-Farber Cancer Institute, Boston, Massachusetts, USA. [3] Harvard Medical School, Boston, Massachusetts, USA. [4] Howard Hughes Medical Institute, Chevy Chase, Maryland, USA. · 1] The Eli and Edythe L. Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA. [2] Massachusetts General Hospital, Boston, Massachusetts, USA. · 1] The Eli and Edythe L. Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA. [2] Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA. [3] Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, USA. · Pubmed 24752078
  • Perini Family Survivors' Center, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA. Electronic address: · Perini Family Survivors' Center, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA. · Division of Urology, Brigham and Women's Hospital, 45 Francis Street, Boston, Boston, MA 02115, USA. · Division of Solid Tumor Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA. · Pubmed 24495697
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · 1] Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA [2] Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Cancer Biology Program, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA. · Pubmed 23770851
2013
  • The Lank Center for Genitourinary Oncology and Solid Tumor Oncology at Dana-Farber Cancer Institute/Brigham & Women's Hospital, Boston, Massachusetts 02115, USA. · Pubmed 23704236
2012
  • Lank Center for Genitourinary Oncology, Division of Solid Tumor Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA. · Pubmed 23040162
  • Departmentof Medical Oncology, Dana Farber Cancer, Institute, Harvard Medical School, 450 Brookline Ave., Boston, Massachusetts 02115. · Departmentof Medicine, Beth Israel Deaconess Medical, Center, Harvard Medical School, 330 Brookline Ave., Boston, Massachusetts 02115. · Pubmed 22127852
2010
  • Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA. · Pubmed 20818862
2017
  • Wanling Xie, Meredith M. Regan, and Christopher J. Sweeney, Dana-Farber Cancer Institute, Boston, MA; Marc Buyse, International Drug Development Institute; Bertrand Tombal, Université Catholique de Louvain, Louvain-la-Neuve; Laurence Collette, European Organisation for Research and Treatment of Cancer, Brussels, Belgium; Susan Halabi, Duke University Medical Center, Durham, NC; Philip W. Kantoff, Memorial Sloan Kettering Cancer Center, New York, NY; Oliver Sartor, Tulane Medical School, New Orleans, LA; Howard Soule, Prostate Cancer Foundation, Santa Monica; Howard M. Sandler, Cedars-Sinai Medical Center, Los Angeles, CA; Noel W. Clarke, The Christie NHS Foundation Trust, Manchester; Matthew R. Sydes, University College London, London, United Kingdom; James J. Dignam, University of Chicago, Chicago, IL; Karim Fizazi, Institut Gustave-Roussy, Villejuif, France; Wendy R. Paruleker, Canadian Cancer Trials Group, Kingston, Ontario, Canada; and Scott G. Williams, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Pubmed 28796587
2016
  • Howard I. Scher, Michael J. Morris, Dana E. Rathkopf, and Susan F. Slovin, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College; David Nanus, NewYork Presbyterian Weill Cornell Medical Center; Lawrence W. Schwartz, NewYork Presbyterian Columbia University Medical Center, New York, NY; Walter M. Stadler, University of Chicago Medicine, Chicago, IL; Celestina Higano and Peter S. Nelson, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, WA; Ethan Basch, University of North Carolina at Chapel Hill, Chapel Hill, NC; Emmanual S. Antonarakis and Michael A. Carducci, Johns Hopkins University School of Medicine, Baltimore, MD; Tomasz M. Beer, Oregon Health and Science University, Portland, OR; Paul G. Corn and Christopher Logothetis, MD Anderson Cancer Center, Houston, TX; Robert Dreicer, University of Virginia School of Medicine, Charlottesville, VA; Daniel J. George, Susan Halabi, and Andrew J. Armstrong, Duke University and Duke Cancer Institute, Durham, NC; Elisabeth I. Heath, Wayne State University Karmanos Cancer Institute, Detroit; and Maha Hussain, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; Wm. Kevin Kelly, Sidney Kimmel School of Medicine at Thomas Jefferson University, Philadelphia, PA; Glenn Liu and George Wilding, University of Wisconsin Carbone Cancer Center, Madison, WI; Mark N. Stein, The Cancer Institute of New Jersey, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, New Brunswick, NJ; Charles S. Ryan and Eric J. Small, University of California Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Oliver Sartor, Tulane School of Medicine, New Orleans, LA; Matthew Raymond Smith, Massachusetts General Hospital Cancer Center and Harvard Medical School; Mary-Ellen Taplin and Philip W. Kantoff, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, Franc · Pubmed 26903579
  • Rana R. McKay, Lillian Werner, Christopher J. Sweeney, Philip W. Kantoff, and Mary-Ellen Taplin, Dana-Farber Cancer Institute, Boston; Robert W. Ross, Bluebird Bio, Cambridge, MA; Amado J. Zurita and Hai T. Tran, MD Anderson Cancer Center, Houston, TX; Justine Y. Bruce, University of Wisconsin Carbone Cancer Center, Madison, WI; Michael A. Carducci, Johns Hopkins University; Arif Hussain, Greenebaum Cancer Center, Baltimore, MD; Mark N. Stein, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ; Elisabeth I. Heath, Karmanos Cancer Institute, Detroit, MI; and Philip W. Kantoff and Susan F. Slovin, Memorial Sloan Kettering Cancer Center, New York, NY. · Rana R. McKay, Lillian Werner, Christopher J. Sweeney, Philip W. Kantoff, and Mary-Ellen Taplin, Dana-Farber Cancer Institute, Boston; Robert W. Ross, Bluebird Bio, Cambridge, MA; Amado J. Zurita and Hai T. Tran, MD Anderson Cancer Center, Houston, TX; Justine Y. Bruce, University of Wisconsin Carbone Cancer Center, Madison, WI; Michael A. Carducci, Johns Hopkins University; Arif Hussain, Greenebaum Cancer Center, Baltimore, MD; Mark N. Stein, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ; Elisabeth I. Heath, Karmanos Cancer Institute, Detroit, MI; and Philip W. Kantoff and Susan F. Slovin, Memorial Sloan Kettering Cancer Center, New York, NY. · Pubmed 27044933
  • Nicholas J. Giacalone, Marian Loffredo, and Anthony V. D'Amico, Brigham and Women's Hospital/Dana-Farber Cancer Institute; Nicholas J. Giacalone, Harvard Radiation Oncology Program, Boston, MA; Jing Wu and Ming-Hui Chen, University of Connecticut, Storrs, CT; Andrew Renshaw, Miami Baptist Hospital, Miami, FL; and Philip W. Kantoff, Memorial Sloan Kettering Cancer Center, New York, NY. · Pubmed 27601545
  • From the University of Washington (C.C.P., M. Beightol, C.M., B.N., H.H.C., B.M., T.W., S. Casadei, P.S.N.) and Fred Hutchinson Cancer Research Center (N.D.S., R.G., P.S.N.) - both in Seattle; the Institute of Cancer Research and Royal Marsden Hospital, London (J.M., S. Carreira, R.E., J.B.); Memorial Sloan Kettering Cancer Center (M.F.W., W.A., M. Berger, L.Z., A.Z., J. Vijai, H.I.S., C.S., N.S., P.W.K., D.S., M.R., K.O.), Weill Cornell Medical College (H.B., O.E., M.A.R.), and the Prostate Cancer Clinical Trials Consortium (J. Vinson, J.F.) - all in New York; the University of Michigan, Ann Arbor (D.R., R.L., M.H., A.C.); Howard Hughes Medical Institute, Chevy Chase, MD (A.C., C.S.); and Dana-Farber Cancer Institute, Boston (A.G., L.G., M.-E.T., S.A., G.C.H., E.M.V.A.). · Pubmed 27433846
2015
  • Michael J. Morris, Steven M. Larson, and Howard I. Scher, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY; Arturo Molina, Thian Kheoh, Shannon L. Matheny, Vahid Naini, and Thomas W. Griffin, Janssen Research & Development, Los Angeles; Eric J. Small and Charles J. Ryan, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA; Johann S. de Bono, Institute for Cancer Research and Royal Marsden Hospital, Sutton, United Kingdom; Christopher J. Logothetis, MD Anderson Cancer Center, Houston, TX; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, France; Paul de Souza, University of Western Sydney School of Medicine, Ingham Institute, Liverpool, New South Wales, Australia; Philip W. Kantoff, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; Celestia S. Higano, University of Washington, Seattle, WA; Jinhui Li, Janssen Research & Development, Raritan, NJ; and Tomasz Burzykowski, International Drug Development Institute, Louvain-la-Neuve, Belgium. · Michael J. Morris, Steven M. Larson, and Howard I. Scher, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY; Arturo Molina, Thian Kheoh, Shannon L. Matheny, Vahid Naini, and Thomas W. Griffin, Janssen Research & Development, Los Angeles; Eric J. Small and Charles J. Ryan, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA; Johann S. de Bono, Institute for Cancer Research and Royal Marsden Hospital, Sutton, United Kingdom; Christopher J. Logothetis, MD Anderson Cancer Center, Houston, TX; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, France; Paul de Souza, University of Western Sydney School of Medicine, Ingham Institute, Liverpool, New South Wales, Australia; Philip W. Kantoff, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; Celestia S. Higano, University of Washington, Seattle, WA; Jinhui Li, Janssen Research & Development, Raritan, NJ; and Tomasz Burzykowski, International Drug Development Institute, Louvain-la-Neuve, Belgium. · Pubmed 25624432
  • Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA. · Pubmed 25135206
2014
  • Mary-Ellen Taplin, Massimo Loda, Rosina T. Lis, Wanling Xie, Zhenyang Jiang, and Philip W. Kantoff, Dana-Farber Cancer Institute, Harvard Medical School; Glenn J. Bubley, Huihui Ye, and Steven P. Balk, Beth Israel Deaconess Medical Center; Jerome P. Richie, Massimo Loda, and Rosina T. Lis, Brigham and Women's Hospital, Boston, MA; Bruce Montgomery, Bruce L. Dalkin, Lawrence D. True, and Alvin M. Matsumoto, University of Washington; Brett T. Marck and Alvin M. Matsumoto, Geriatric Research, Education and Clinical Center, Veterans' Affairs Puget Sound Health Care System; Elahe A. Mostaghel and Peter S. Nelson, Fred Hutchinson Cancer Research Center, Seattle, WA; Christopher J. Logothetis, John W. Davis, and Patricia Troncoso, University of Texas MD Anderson Cancer Center, Houston, TX; Martin G. Sanda, Emory University School of Medicine, Atlanta, GA; Massimo Loda, King's College London, London, United Kingdom; Trevor M. Penning and Daniel Tamae, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; and Christopher M. Haqq, NamPhuong Tran, Weimin Peng, Thian Kheoh, and Arturo Molina, Janssen Research and Development, Los Angeles, CA. · Mary-Ellen Taplin, Massimo Loda, Rosina T. Lis, Wanling Xie, Zhenyang Jiang, and Philip W. Kantoff, Dana-Farber Cancer Institute, Harvard Medical School; Glenn J. Bubley, Huihui Ye, and Steven P. Balk, Beth Israel Deaconess Medical Center; Jerome P. Richie, Massimo Loda, and Rosina T. Lis, Brigham and Women's Hospital, Boston, MA; Bruce Montgomery, Bruce L. Dalkin, Lawrence D. True, and Alvin M. Matsumoto, University of Washington; Brett T. Marck and Alvin M. Matsumoto, Geriatric Research, Education and Clinical Center, Veterans' Affairs Puget Sound Health Care System; Elahe A. Mostaghel and Peter S. Nelson, Fred Hutchinson Cancer Research Center, Seattle, WA; Christopher J. Logothetis, John W. Davis, and Patricia Troncoso, University of Texas MD Anderson Cancer Center, Houston, TX; Martin G. Sanda, Emory University School of Medicine, Atlanta, GA; Massimo Loda, King's College London, London, United Kingdom; Trevor M. Penning and Daniel Tamae, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; and Christopher M. Haqq, NamPhuong Tran, Weimin Peng, Thian Kheoh, and Arturo Molina, Janssen Research and Development, Los Angeles, CA. · Pubmed 25311217
  • Perini Family Survivors' Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Pubmed 24962506
  • Department of Medicine, Dana-Farber Cancer Institute, Boston, Massachusetts. · Pubmed 24668612
  • Harvard Radiation Oncology Program, Harvard Medical School, Boston, Massachusetts. · Pubmed 24604289
  • Elahe A. Mostaghel, Rachel Hunter Merrill, and Roman Gulati, Fred Hutchinson Cancer Research Center; Elahe A. Mostaghel, Peter S. Nelson, Paul Lange, Daniel W. Lin, William Ellis, Robert Vessella, and Bruce Montgomery, University of Washington; Brett Marck, Alvin M. Matsumoto, and Lawrence D. True, Veterans Affairs Puget Sound Health Care System, Seattle, WA; Mary Ellen Taplin and Philip Kantoff, Dana-Farber Cancer Institute, Harvard Medical School; Steven Balk, Beth Israel Deaconess Medical Center, Boston, MA; and Daniel Tamae and Trevor Penning, University of Pennsylvania, Philadelphia, PA. · Pubmed 24323034
  • Department of Medicine, Dana-Farber Cancer Institute, Boston, Massachusetts. · Pubmed 24132762
2013
  • Affiliations of authors: Department of Epidemiology (AP, AM, MF, REG, KLP, JRR, EJN, MJS, ELG, LAM) and Department of Nutrition (MJS, ELG), Harvard School of Public Health, Boston, MA; Channing Division of Network Medicine (AP, KLP, JRR, MJS, ELG, LAM) and Division of Preventive Medicine (HDS) , Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA; Department of Pathology, Brigham and Women's Hospital, Boston, MA (RTL, ECS, ML); Center for Molecular Oncologic Pathology (RTL, RF, ECS, MF, SF, NEM, ML), Department of Radiation Oncology (NEM), and Lank Center for Genitourinary Oncology (PWK), Dana-Farber Cancer Institute, Boston, MA; University of Dublin, Trinity College, Dublin, Ireland (RF, SF); Pathology Unit, Addarii Institute, S. Orsola-Malpighi Hospital, Bologna, Italy (MF); Department of Medicine, McGill University, Montreal, QC, Canada (MP). · Pubmed 24292212
  • Harvard Radiation Oncology Program, Harvard Medical School, Boston, Massachusetts. · Pubmed 23798006
  • Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Institute for Clinical and Economic Review, Institute for Technology Assessment, Boston, MA 02115, USA. · Pubmed 23778902
  • Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute and Harvard Medical School, 450 Brookline Avenue, Boston, MA 02215, USA. · Pubmed 23719969
  • Harvard Medical School, Boston, MA 02115, USA. · Pubmed 23622249
  • Harvard Radiation Oncology Program, Boston, Massachusetts, USA. · Pubmed 23382116
  • Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts 02215, USA. · Pubmed 22887127
  • The Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. · Pubmed 24114731
2012
  • Lank Center for Genitourinary Oncology, Department of Medicine, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02215, USA. · Pubmed 22928480
  • Dana Farber Cancer Institute, Boston, Massachusetts, USA. · Pubmed 22282219
  • Massachusetts General Hospital Cancer Center, Boston, MA 02114, USA. · Pubmed 21930687
  • Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA. · Pubmed 23413607
  • Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA. · Pubmed 23239736
  • Dana-Farber Cancer Institute, 450 Brookline Ave., Boston, MA 02215, USA. · Pubmed 23138168
  • Division of Solid Tumor Oncology, Department of Medicine, Dana-Farber Cancer Institute, Boston, MA, USA. · Pubmed 23059047
  • Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA. · Pubmed 22736790
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA. · Pubmed 22730461
  • Department of Radiation Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. · Pubmed 22564379
  • Harvard Radiation Oncology Program, Department of Radiation Oncology, Dana Farber Cancer Institute, Boston, Massachusetts 02115, USA. · Pubmed 22498212
  • Department of Radiation Oncology, Brigham and Women's Hospital and Dana Farber Cancer Institute, Boston, MA 02115, USA. · Pubmed 22112793
  • Department of Radiation Oncology, Dana Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02215, USA. · Pubmed 21708431
2011
  • Brigham and Women's Hospital, Boston, MA 02115, USA. · Pubmed 22042952
  • Lank Center for Genitourinary Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, 44 Binney St., Boston, MA 02115, USA. · Pubmed 21958520
  • Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02215, USA. · Pubmed 21900597
  • Department of Medical Oncology and Cancer Vaccine Center, Dana-Farber Cancer Institute, Boston, MA 02215, USA. · Pubmed 21700764
  • Dana-Farber Cancer Institute, Harvard Medical School, Dana 710B, 44 Binney St., Boston, MA 02115, USA. · Pubmed 21606417
  • Department of Epidemiology, Harvard School of Public Health, 677 Huntington Ave, Boston, MA 02115, USA. · Pubmed 21537050
  • Department of Nutrition, Harvard School of Public Health, 655 Huntington Ave, Boston, MA 02115, USA. · Pubmed 21537045
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA. · Pubmed 21367958
  • The Broad Institute of Harvard and MIT, Cambridge, Massachusetts 02142, USA. · Pubmed 21307934
  • Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts 02115, USA. · Pubmed 21135144
  • Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA. · Pubmed 20862742
  • Department of Radiation Oncology, Dana Farber Cancer Institute and Brigham and Women's Hospital, Boston, MA 02115, USA. · Pubmed 20605366
  • Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. · Pubmed 20477822
2010
  • Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA. · Pubmed 21121759
  • Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA. · Pubmed 21119084
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America. · Pubmed 21085629
  • Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA. · Pubmed 20978177
  • Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts 02115, USA. · Pubmed 20855462
  • Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts 02115, USA. · Pubmed 20615892
  • Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115, USA. · Pubmed 20424130
  • Laboratory of Nanomedicine & Biomaterials, Department of Anesthesia, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA. · Pubmed 20394530
  • Department of Pathology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115, USA. · Pubmed 20388772
  • Department of Radiation Oncology, Dana Farber Cancer Institute and Brigham and Women's Hospital, Boston, Massachusetts 02115, USA. · Pubmed 19957321
  • Department of Radiation Oncology, Dana Farber Cancer Institute and Brigham and Women's Hospital, Boston, Massachusetts 02115, USA. · Pubmed 19864082
  • Lank Center for Genitourinary Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02115, USA. · Pubmed 19863532
  • Harvard Radiation Oncology Program, Department of Radiation Oncology, Brigham and Women's Hospital, Boston, MA 02115, USA. · Pubmed 19395186
2009
  • Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA 02115, USA. · Pubmed 19887483
  • Division of Hematology/Oncology, Massachusetts General Hospital, Boston, MA 02114, USA. · Pubmed 19403935
  • Harvard Radiation Oncology Program, Harvard Medical School, Boston, MA, USA. · Pubmed 19858385
  • Dana-Farber Cancer Institute, Boston, MA, USA. · Pubmed 19815488
  • Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02115, USA. · Pubmed 19632176
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA. · Pubmed 19549893
  • Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA. · Pubmed 19431146
  • Department of Radiation Oncology, Brigham and Women's Hospital and Dana Farber Cancer Institute, Boston, MA 02215, USA. · Pubmed 19395184
  • Department of Epidemiology, Harvard School of Public Health, Harvard University, Cambridge, Massachusetts, USA. · Pubmed 19366828
  • Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02115, USA. · Pubmed 19351832
  • Dana-Farber Cancer Institute/Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA. · Pubmed 19152438
2008
  • Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA. · Pubmed 18399827
  • Department of Radiation Oncology, Brigham and Women's Hospital, Boston, Massachusetts 02215, USA. · Pubmed 18291508
  • Department of Radiation Oncology, Brigham and Women's Hospital and Dana Farber Cancer Institute, Boston, MA 02215, USA. · Pubmed 18980297
  • Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115, USA. · Pubmed 18827812
  • Laboratory of Nanomedicine and Biomaterials, Department of Anesthesia, Brigham and Women's Hospital and Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA. · Pubmed 18613203
  • Channing Laboratory, Brigham and Women's Hospital, Boston, MA 02115, USA. · Pubmed 18583469
  • Department of Radiation, Brigham and Women's Hospital and Dana Farber Cancer Institute, Boston, MA 02215, USA. · Pubmed 18565884
  • Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA. · Pubmed 18505969
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA. · Pubmed 18302198
  • Harvard Medical School, Dana Farber Cancer Institute, Boston, Massachusetts 02115, USA. · Pubmed 18293426
  • Dana-Farber Cancer Institute, Dana 710-C, 44 Binney St, Boston, MA 02115, USA. · Pubmed 18281655
  • Department of Radiation Oncology, Brigham and Women's Hospital and Dana Farber Cancer Institute, Boston, Massachusetts 02115, USA. · Pubmed 18212313
  • Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, 181 Longwood Avenue, Boston, MA 02115, USA. · Pubmed 18199732
  • Lank Center for Genitourinary Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02115, USA. · Pubmed 18184327
2007
  • Harvard Medical School, Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. · Pubmed 17396482
  • Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, 44 Binney Street, Boston, MA 02115, USA. · Pubmed 17509304
  • Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, 181 Longwood Avenue, Boston, MA 02115, USA. · Pubmed 18006911
  • Laboratory of Nanomedicine and Biomaterials, Department of Anesthesiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA. · Pubmed 17854227
  • Diana-Farber Cancer Institute, Center for Genitourinary Oncology, Massachusetts General Hospital, Boston, MA, USA. · Pubmed 17669139
  • Departments of Radiation Oncology and Medicine, Cardiovascular Division, Brigham and Women's Hospital and Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA. · Pubmed 17557956
  • Lank Center for Genitourinary Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA. · Pubmed 17542988
  • Department of Biostatistics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Pubmed 17459967
  • Division of Hematology and Oncology and Endocrine Unit, Massachusetts General Hospital, Boston, MA 02114, USA. · Pubmed 17369566
  • Department of Pathology, Brigham and Women's Hospital, Boston, MA 02115-6110, USA. · Pubmed 17237811
Memorial Sloan-Kettering Cancer Center
2017
  • Dana-Farber Cancer Institute, Boston, Massachusetts. · University of Washington, Seattle, Washington. · Beth Israel Deaconess Medical Center, Boston, Massachusetts. · Veterans Affairs Puget Sound Health Care System, Seattle, Washington. · Beilinson Hospital, Petah Tikva, Israel. · McMaster University, Ontario, Canada. · Memorial Sloan Kettering Cancer Center, New York, New York. · Dana-Farber Cancer Institute, Boston, Massachusetts. · Pubmed 27683182
  • Division of Urology, Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America. · Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, United States of America. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America. · Pubmed 28886115
  • Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland. · Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts. · Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 28762529
  • Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts. · Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center, Tampa, Florida. · Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. · Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Statistics, Ohio State University, Columbus, Ohio. · Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts. · Department of Epidemiology, Boston University School of Public Health, Boston, Massachusetts. · Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, Massachusetts. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Histopathology, St. James's Hospital and Trinity College Dublin Medical School, Dublin, Ireland. · Koch Institute for Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts. · Department of Nutrition, Harvard T. H. Chan School of Public Health, Boston, Massachusetts. · Pubmed 28700821
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Surgery, Division of Urology, Brigham and Women's Hospital, Boston, Massachusetts. · Division of Population Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Physics of Complex Systems Eotvos Lorand University, Budapest, Hungary. · Department of Medicine, Tulane Cancer Center, New Orleans, Louisiana. · Department of Pediatrics, Boston Children's Hospital, Boston, Massachusetts. · Department of Medicine, Division of Hematology and Oncology, Tisch Cancer Institute, New York, New York. · Department of Medicine, Memorial Sloan Kettering Cancer Institute, New York, New York. · Pubmed 28608931
  • Department of Medicine, University of Washington, Seattle, Washington. · Department of Pathology, University of Washington, Seattle, Washington. · Princess Margaret Cancer Centre, Toronto, Canada. · Department of Urologic Sciences, University of British Columbia, Vancouver, Canada. · Beth Israel Deaconess Medical Center, Boston, Massachusetts. · Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, Washington. · Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington. · BC Cancer Agency and University of British Columbia, Vancouver, Canada. · Department of Urology, University of Washington, Seattle, Washington. · Department of Urology, Emory University, Atlanta, Georgia. · Medivation, Inc., San Francisco, California. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Memorial Sloan Kettering Cancer Center, New York, New York. · Geriatric Research, Education and Clinical Center, VA Puget Sound Health Care System, and Department of Medicine, Division of Gerontology & Geriatric Medicine, University of Washington, Seattle, Washington. · Department of Medicine, University of Washington, Seattle, Washington. · Brigham and Women's Hospital, Boston, Massachusetts. · Astellas Pharma, Inc., Northbrook, Illinois. · Pubmed 28151719
  • Harvard Radiation Oncology Program, Harvard Medical School, Boston, MA, USA. · Department of Statistics, University of Connecticut, Storrs, CT, USA. · Department of Radiation Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, MA, USA. · Department of Pathology, Miami Baptist Hospital, Miami, FL, USA. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Pubmed 28117382
  • Harvard Radiation Oncology Program, Brigham and Women's Hospital, Boston, Massachusetts2Department of Radiation Oncology, Brigham and Women's Hospital, Boston, Massachusetts3Dana Farber Cancer Institute, Boston, Massachusetts. · Department of Statistics, University of Connecticut, Storrs, Connecticut. · Department of Radiation Oncology, Brigham and Women's Hospital, Boston, Massachusetts3Dana Farber Cancer Institute, Boston, Massachusetts. · Department of Pathology, Baptist Hospital, Miami, Florida. · Department of Medicine, Memorial Sloan Kettering Institute, New York, New York. · Pubmed 28097317
  • Department of Radiation Oncology, Brigham and Women's Hospital, Boston, MA, USA. · Department of Statistics, University of Connecticut, Storrs, CT, USA. · Department of Pathology, Miami Baptist Hospital, Miami, FL, USA. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Pubmed 27824043
  • Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Urology and Medicine, Tulane University School of Medicine, New Orleans, Los Angeles. · Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 27489290
2016
  • Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Pubmed 27502737
  • Perini Family Survivors' Center, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, USA; Department of Pediatrics, Harvard Medical School, 25 Shattuck Street, Boston, MA, USA. Electronic address: · Perini Family Survivors' Center, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, USA; Department of Pediatrics, Harvard Medical School, 25 Shattuck Street, Boston, MA, USA. Electronic address: · Perini Family Survivors' Center, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, USA; Department of Pediatrics, Harvard Medical School, 25 Shattuck Street, Boston, MA, USA. Electronic address: · Department of Urology, Weill Cornell Medical Center, 1300 York Avenue, New York, NY, USA. Electronic address: · Department of Medicine, Memorial Sloan Kettering Cancer Center, 600 Third Avenue, New York, NY, USA. Electronic address: · Perini Family Survivors' Center, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, USA; Department of Pediatrics, Harvard Medical School, 25 Shattuck Street, Boston, MA, USA. Electronic address: · Pubmed 27439668
  • Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. · Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. · Interne de Paris, Urology, Paris, France. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Cancer Biology, Cleveland Clinic, Cleveland, Ohio. · Pubmed 27325180
  • Departments Of Epidemiology & Biostatistics and Urology, University of CA San Francisco. · SWOG Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, WA. · Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston MA. · Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital/Harvard Medical School, Boston, MA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston MA. · Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan Cancer Center, Michigan. · Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH. · The Cancer Therapy and Research Center, University of Texas Health Science Center at San Antonio, San Antonio, TX. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 27197287
  • Department of Urology, Osaka Medical College, Osaka 569-8686, Japan; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065; · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215; · Department of Urology, Osaka Medical College, Osaka 569-8686, Japan; · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065; · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215; Harvard Medical School, Boston, MA 02215 · Pubmed 27185910
2017
  • Wanling Xie, Meredith M. Regan, and Christopher J. Sweeney, Dana-Farber Cancer Institute, Boston, MA; Marc Buyse, International Drug Development Institute; Bertrand Tombal, Université Catholique de Louvain, Louvain-la-Neuve; Laurence Collette, European Organisation for Research and Treatment of Cancer, Brussels, Belgium; Susan Halabi, Duke University Medical Center, Durham, NC; Philip W. Kantoff, Memorial Sloan Kettering Cancer Center, New York, NY; Oliver Sartor, Tulane Medical School, New Orleans, LA; Howard Soule, Prostate Cancer Foundation, Santa Monica; Howard M. Sandler, Cedars-Sinai Medical Center, Los Angeles, CA; Noel W. Clarke, The Christie NHS Foundation Trust, Manchester; Matthew R. Sydes, University College London, London, United Kingdom; James J. Dignam, University of Chicago, Chicago, IL; Karim Fizazi, Institut Gustave-Roussy, Villejuif, France; Wendy R. Paruleker, Canadian Cancer Trials Group, Kingston, Ontario, Canada; and Scott G. Williams, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Pubmed 28796587
2016
  • Howard I. Scher, Michael J. Morris, Dana E. Rathkopf, and Susan F. Slovin, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College; David Nanus, NewYork Presbyterian Weill Cornell Medical Center; Lawrence W. Schwartz, NewYork Presbyterian Columbia University Medical Center, New York, NY; Walter M. Stadler, University of Chicago Medicine, Chicago, IL; Celestina Higano and Peter S. Nelson, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, WA; Ethan Basch, University of North Carolina at Chapel Hill, Chapel Hill, NC; Emmanual S. Antonarakis and Michael A. Carducci, Johns Hopkins University School of Medicine, Baltimore, MD; Tomasz M. Beer, Oregon Health and Science University, Portland, OR; Paul G. Corn and Christopher Logothetis, MD Anderson Cancer Center, Houston, TX; Robert Dreicer, University of Virginia School of Medicine, Charlottesville, VA; Daniel J. George, Susan Halabi, and Andrew J. Armstrong, Duke University and Duke Cancer Institute, Durham, NC; Elisabeth I. Heath, Wayne State University Karmanos Cancer Institute, Detroit; and Maha Hussain, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; Wm. Kevin Kelly, Sidney Kimmel School of Medicine at Thomas Jefferson University, Philadelphia, PA; Glenn Liu and George Wilding, University of Wisconsin Carbone Cancer Center, Madison, WI; Mark N. Stein, The Cancer Institute of New Jersey, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, New Brunswick, NJ; Charles S. Ryan and Eric J. Small, University of California Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Oliver Sartor, Tulane School of Medicine, New Orleans, LA; Matthew Raymond Smith, Massachusetts General Hospital Cancer Center and Harvard Medical School; Mary-Ellen Taplin and Philip W. Kantoff, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, Franc · Pubmed 26903579
  • Rana R. McKay, Lillian Werner, Christopher J. Sweeney, Philip W. Kantoff, and Mary-Ellen Taplin, Dana-Farber Cancer Institute, Boston; Robert W. Ross, Bluebird Bio, Cambridge, MA; Amado J. Zurita and Hai T. Tran, MD Anderson Cancer Center, Houston, TX; Justine Y. Bruce, University of Wisconsin Carbone Cancer Center, Madison, WI; Michael A. Carducci, Johns Hopkins University; Arif Hussain, Greenebaum Cancer Center, Baltimore, MD; Mark N. Stein, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ; Elisabeth I. Heath, Karmanos Cancer Institute, Detroit, MI; and Philip W. Kantoff and Susan F. Slovin, Memorial Sloan Kettering Cancer Center, New York, NY. · Rana R. McKay, Lillian Werner, Christopher J. Sweeney, Philip W. Kantoff, and Mary-Ellen Taplin, Dana-Farber Cancer Institute, Boston; Robert W. Ross, Bluebird Bio, Cambridge, MA; Amado J. Zurita and Hai T. Tran, MD Anderson Cancer Center, Houston, TX; Justine Y. Bruce, University of Wisconsin Carbone Cancer Center, Madison, WI; Michael A. Carducci, Johns Hopkins University; Arif Hussain, Greenebaum Cancer Center, Baltimore, MD; Mark N. Stein, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ; Elisabeth I. Heath, Karmanos Cancer Institute, Detroit, MI; and Philip W. Kantoff and Susan F. Slovin, Memorial Sloan Kettering Cancer Center, New York, NY. · Pubmed 27044933
  • Nicholas J. Giacalone, Marian Loffredo, and Anthony V. D'Amico, Brigham and Women's Hospital/Dana-Farber Cancer Institute; Nicholas J. Giacalone, Harvard Radiation Oncology Program, Boston, MA; Jing Wu and Ming-Hui Chen, University of Connecticut, Storrs, CT; Andrew Renshaw, Miami Baptist Hospital, Miami, FL; and Philip W. Kantoff, Memorial Sloan Kettering Cancer Center, New York, NY. · Pubmed 27601545
  • From the University of Washington (C.C.P., M. Beightol, C.M., B.N., H.H.C., B.M., T.W., S. Casadei, P.S.N.) and Fred Hutchinson Cancer Research Center (N.D.S., R.G., P.S.N.) - both in Seattle; the Institute of Cancer Research and Royal Marsden Hospital, London (J.M., S. Carreira, R.E., J.B.); Memorial Sloan Kettering Cancer Center (M.F.W., W.A., M. Berger, L.Z., A.Z., J. Vijai, H.I.S., C.S., N.S., P.W.K., D.S., M.R., K.O.), Weill Cornell Medical College (H.B., O.E., M.A.R.), and the Prostate Cancer Clinical Trials Consortium (J. Vinson, J.F.) - all in New York; the University of Michigan, Ann Arbor (D.R., R.L., M.H., A.C.); Howard Hughes Medical Institute, Chevy Chase, MD (A.C., C.S.); and Dana-Farber Cancer Institute, Boston (A.G., L.G., M.-E.T., S.A., G.C.H., E.M.V.A.). · Pubmed 27433846
2015
  • Michael J. Morris, Steven M. Larson, and Howard I. Scher, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY; Arturo Molina, Thian Kheoh, Shannon L. Matheny, Vahid Naini, and Thomas W. Griffin, Janssen Research & Development, Los Angeles; Eric J. Small and Charles J. Ryan, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA; Johann S. de Bono, Institute for Cancer Research and Royal Marsden Hospital, Sutton, United Kingdom; Christopher J. Logothetis, MD Anderson Cancer Center, Houston, TX; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, France; Paul de Souza, University of Western Sydney School of Medicine, Ingham Institute, Liverpool, New South Wales, Australia; Philip W. Kantoff, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; Celestia S. Higano, University of Washington, Seattle, WA; Jinhui Li, Janssen Research & Development, Raritan, NJ; and Tomasz Burzykowski, International Drug Development Institute, Louvain-la-Neuve, Belgium. · Michael J. Morris, Steven M. Larson, and Howard I. Scher, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY; Arturo Molina, Thian Kheoh, Shannon L. Matheny, Vahid Naini, and Thomas W. Griffin, Janssen Research & Development, Los Angeles; Eric J. Small and Charles J. Ryan, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA; Johann S. de Bono, Institute for Cancer Research and Royal Marsden Hospital, Sutton, United Kingdom; Christopher J. Logothetis, MD Anderson Cancer Center, Houston, TX; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, France; Paul de Souza, University of Western Sydney School of Medicine, Ingham Institute, Liverpool, New South Wales, Australia; Philip W. Kantoff, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; Celestia S. Higano, University of Washington, Seattle, WA; Jinhui Li, Janssen Research & Development, Raritan, NJ; and Tomasz Burzykowski, International Drug Development Institute, Louvain-la-Neuve, Belgium. · Pubmed 25624432
2013
  • From 1Roswell Park Cancer Institute; 2Dana-Farber/Brigham and Women's Cancer Center; 3Duke Cancer Institute; 4The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute; 5Huntsman Cancer Institute at the University of Utah; 6Memorial Sloan-Kettering Cancer Center; 7Fred & Pamela Buffett Cancer Center at The Nebraska Medical Center; 8Prostate Health Education Network; 9University of Washington/Seattle Cancer Care Alliance; 10Fox Chase Cancer Center; 11City of Hope Comprehensive Cancer Center; 12Massachusetts General Hospital Cancer Center; 13Robert H. Lurie Comprehensive Cancer Center of Northwestern University; 14Vanderbilt-Ingram Cancer Center; 15University of Michigan Comprehensive Cancer Center; 16Moffitt Cancer Center; 17St. Jude Children's Research Hospital/The University of Tennessee Health Science Center; 18UCSF Helen Diller Family Comprehensive Cancer Center; 19The University of Texas MD Anderson Cancer Center; 20Patient Advocate; 21Stanford Cancer Institute; 22Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; 23The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; and 24National Comprehensive Cancer Network. · Pubmed 24335682
2012
  • Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Pubmed 22802323
2009
  • Genitourinary Oncology Service, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA. · Pubmed 19213669
2008
  • Genitourinary Oncology Service, Department of Medicine, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10065, USA. · Pubmed 18309951
Miscellaneous institutions in New York City
2016
  • Shanghai Key Laboratory of Tuberculosis, Shanghai Pulmonary Hospital, Shanghai 200433, China. · Department of Bioinformatics, School of Life Sciences and Technology, Tongji University, Shanghai 200092, China. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA. · Harvard Medical School, Boston, Massachusetts 02215, USA. · Department of Pathology, University of Massachusetts Medical School, Worcester, Massachusetts 01655, USA. · Department of Molecular and Cellular Biology, Harvard University, Cambridge, Massachusetts 02138, USA. · Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, Massachusetts 02138, USA. · Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, Massachusetts 02142, USA. · Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA. · Department of Pathology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA. · Department of Bioinformatics and Computational Biology, Division of Quantitative Sciences, University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. · Department of Medicine Memorial Sloan Kettering Cancer Center 1275 York Avenue, New York, New York 10065, USA. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute and Harvard School of Public Health, Boston, Massachusetts 02215, USA. · Pubmed 26975529
Unspecified
2014
  • Center for Molecular Oncologic Pathology; Departments of Department of Histopathology, St. James's Hospital and Trinity College Dublin Medical School, Dublin, Ireland · Channing Division of Network Medicine, Department of Medicine; Department of Epidemiology, Harvard School of Public Health; and. · Center for Molecular Oncologic Pathology; Departments of. · Center for Molecular Oncologic Pathology; Departments of Department of Histopathology, St. James's Hospital and Trinity College Dublin Medical School, Dublin, Ireland. · Radiation Oncology, Dana Farber Cancer Institute; · Medical Oncology and. · Division of Preventive Medicine, Brigham and Women's Hospital; · Center for Molecular Oncologic Pathology; Departments of Medical Oncology and. · Pubmed 24687926
Miscellaneous institutions in Mountain View
2010
  • Medical Director, BN ImmunoTherapeutics, 2425 Garcia Ave, Mountain View, CA 94043, USA. · Pubmed 20100959
Miscellaneous institutions in Boston
2007
  • Lank Center for Genitourinary Oncology, Boston, Massachusetts, USA. · Pubmed 17644118
2013
  • Division of Medical Oncology, Department of Medicine, Lank Center for Genitourinary Oncology, Boston, MA 02215, USA. · Pubmed 23452809
66 Other Locations Show
Yearly article counts 01319271818231820142018
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.